#  @Longroaderstar Longroader Longroader posts on X about $arwr, $prqr, $sgmo, $vtyx the most. They currently have [---------] followers and [---] posts still getting attention that total [-------] engagements in the last [--] hours. ### Engagements: [-------] [#](/creator/twitter::1468407885432770561/interactions)  - [--] Week [-----] -7.30% - [--] Month [-----] -57% - [--] Months [-------] +196% - [--] Year [-------] +81% ### Mentions: [--] [#](/creator/twitter::1468407885432770561/posts_active)  - [--] Month [--] -69% - [--] Months [---] +198% - [--] Year [---] +79% ### Followers: [---------] [#](/creator/twitter::1468407885432770561/followers)  - [--] Week [---] +0.45% - [--] Month [---] +3.70% - [--] Months [---] +58% - [--] Year [---] +127% ### CreatorRank: [---------] [#](/creator/twitter::1468407885432770561/influencer_rank)  ### Social Influence **Social category influence** [stocks](/list/stocks) [finance](/list/finance) [countries](/list/countries) [cryptocurrencies](/list/cryptocurrencies) [technology brands](/list/technology-brands) [us election](/list/us-election) [travel destinations](/list/travel-destinations) [exchanges](/list/exchanges) [celebrities](/list/celebrities) [social networks](/list/social-networks) **Social topic influence** [$arwr](/topic/$arwr), [$prqr](/topic/$prqr) #1, [$sgmo](/topic/$sgmo), [$vtyx](/topic/$vtyx), [$xbi](/topic/$xbi), [$lly](/topic/$lly), [$pfe](/topic/$pfe), [$wve](/topic/$wve), [$mgx](/topic/$mgx), [sanofi](/topic/sanofi) **Top accounts mentioned or mentioned by** [@rnaianalyst](/creator/undefined) [@biotechanalysst](/creator/undefined) [@proqr](/creator/undefined) [@mchilberg](/creator/undefined) [@drmakaryfda](/creator/undefined) [@bioboyscout](/creator/undefined) [@usfda](/creator/undefined) [@zinselmeyerb](/creator/undefined) [@seedy19tron](/creator/undefined) [@bioman944918473](/creator/undefined) [@francaole](/creator/undefined) [@seckennedy](/creator/undefined) [@nihdirectorjay](/creator/undefined) [@drozcms](/creator/undefined) [@pawcio2009](/creator/undefined) [@yaireinhorn](/creator/undefined) [@igisci](/creator/undefined) [@mattyjc](/creator/undefined) [@tuckerblows](/creator/undefined) [@smarting1121](/creator/undefined) **Top assets mentioned** [Arrowhead Research Corporation (ARWR)](/topic/$arwr) [Ventyx Biosciences, Inc. (VTYX)](/topic/$vtyx) [Eli Lilly and Company (LLY)](/topic/$lly) [Pfizer, Inc. (PFE)](/topic/$pfe) [Wave Life Sciences Ltd. Ordinary Shares (WVE)](/topic/$wve) [Metagenomi Technologies, LLC (MGX)](/topic/$mgx) [Sanofi (SNY)](/topic/sanofi) [Iovance Biotherapeutics, Inc. Common Stock (IOVA)](/topic/$iova) [Sarepta Therapeutics, Inc. (SRPT)](/topic/$srpt) [Vir Biotechnology, Inc. Common Stock (VIR)](/topic/$vir) [Prime Medicine, Inc. (PRME)](/topic/$prme) [Viking Therapeutics, Inc (VKTX)](/topic/$vktx) [Ionis Pharmaceuticals, Inc. Common Stock (IONS)](/topic/$ions) [CRISPR Therapeutics AG (CRSP)](/topic/$crsp) [Intellia Therapeutics, Inc (NTLA)](/topic/$ntla) [Alnylam Pharmaceuticals, Inc. (ALNY)](/topic/$alny) [Abivax SA (ABVX)](/topic/$abvx) [Novo-Nordisk (NVO)](/topic/$nvo) [BEAM (BEAM)](/topic/$beam) [GSK plc (GSK)](/topic/$gsk) [Smart Layer Network (SLN)](/topic/$sln) [Tourmaline Bio, Inc. (TRML)](/topic/$trml) [Cidara Therapeutics, Inc. (CDTX)](/topic/$cdtx) [Novartis AG (NVS)](/topic/novartis) [Synthetify (SNY)](/topic/$sny) [uniQure N.V. (QURE)](/topic/$qure) [NVIDIA Corp. (NVDA)](/topic/$nvda) [Moderna Inc (MRNA)](/topic/$mrna) [Kronos Bio, Inc. (KRON)](/topic/$kron) [Poseida Therapeutics, Inc. (PSTX)](/topic/$pstx) [Arvinas, Inc (ARVN)](/topic/$arvn) [BioAge Labs, Inc. (BIOA)](/topic/$bioa) [Avidity Biosciences, Inc. (RNA)](/topic/$rna) [Freeline Therapeutics Holdings plc (FRLN)](/topic/$frln) [Amicus Therapeutics, Inc (FOLD)](/topic/$fold) [Johnson & Johnson (JNJ)](/topic/$jnj) ### Top Social Posts Top posts by engagements in the last [--] hours "@RNAiAnalyst $tpst Chapter [--] obviously doesnt bother them" [X Link](https://x.com/Longroaderstar/status/1712644555152269741) 2023-10-13T01:40Z [--] followers, [--] engagements "$AVRO $FRLN Gaucher cousins approx cash level buyout. So cheap now" [X Link](https://x.com/Longroaderstar/status/1714889742884491286) 2023-10-19T06:22Z [--] followers, [---] engagements "$LLY Small and early stage $PRQR" [X Link](https://x.com/Longroaderstar/status/1744900250190659846) 2024-01-10T01:53Z [--] followers, [---] engagements "$PRQR Van Herk picked up 5.3% in Sept [----]. Strong buying last [--] weeks. $LLY feeling the squeeze" [X Link](https://x.com/Longroaderstar/status/1747631492946125095) 2024-01-17T14:46Z [--] followers, [---] engagements "$prqr $lly Similar structure deal entering Phase [--] ProQR-Lily deal update next" [X Link](https://x.com/Longroaderstar/status/1749724300368912886) 2024-01-23T09:22Z [--] followers, [---] engagements "$prqr Current mcap $165m $WVE $499m $KRRO $405m Expect this gap to narrow as clinicals trials initiate later this year" [X Link](https://x.com/Longroaderstar/status/1761025226169807081) 2024-02-23T13:48Z [--] followers, [---] engagements "$SGMO 1/4 Potential of fabry disease market Estimates range from [-----] to [-----] individuals with fabry gene in the US alone" [X Link](https://x.com/Longroaderstar/status/1764591154572779816) 2024-03-04T09:58Z [--] followers, [----] engagements "2/4 Leading treatment is Fabrazyme an enzyme replacement therapy from Sanofi. Latest FY2023 sales figures at 991m ($1.25b) increasing patient accurals" [X Link](https://x.com/Longroaderstar/status/1764592213898711266) 2024-03-04T10:02Z [---] followers, [---] engagements "3/4 Novel treatment Galafold from Amicus Therapeutics an oral option for adults with confirmed Fabry disease and anamenableGLAgenevariant. Full year sales FY23 was $387m projecting strong FY24 growth between 11% to 16%" [X Link](https://x.com/Longroaderstar/status/1764594033064878474) 2024-03-04T10:09Z [---] followers, [---] engagements "$sgmo $biib $nvs $vygr Reshuffle the cards. Pick the better capsid. STAC-BBB https://ir.voyagertherapeutics.com/news-releases/news-release-details/voyager-therapeutics-enters-capsid-license-agreement-and https://ir.voyagertherapeutics.com/news-releases/news-release-details/voyager-therapeutics-enters-capsid-license-agreement-and" [X Link](https://x.com/Longroaderstar/status/1768431161645429058) 2024-03-15T00:16Z [--] followers, [----] engagements "$SWAV $JNJ #xbi Money coming off sidelines. https://www.businesswire.com/news/home/20240405052557/en/ https://www.businesswire.com/news/home/20240405052557/en/" [X Link](https://x.com/Longroaderstar/status/1776207882826166572) 2024-04-05T11:18Z [--] followers, [--] engagements "$prqr All eyes on $LLY post strawmen challenges. Can easily go to $5 if $LLY exercises its options. Sitryx is a good case study. https://www.sitryx.com/news/sitryx-announces-partner-lilly-exercises-option-to-sit-011-for-chronic-autoimmune-and-inflammatory-diseases https://www.sitryx.com/news/sitryx-announces-partner-lilly-exercises-option-to-sit-011-for-chronic-autoimmune-and-inflammatory-diseases" [X Link](https://x.com/Longroaderstar/status/1782413053725970458) 2024-04-22T14:16Z [--] followers, [---] engagements "@BioMan944918473 @RNAiAnalyst $PRQR $LLY [--] years of silence finally [--] poster. This AGM shareholders must push for more data" [X Link](https://x.com/Longroaderstar/status/1782775917028508077) 2024-04-23T14:17Z [--] followers, [---] engagements "$ARWR Busy month with [--] late breakers https://ir.arrowheadpharma.com/news-releases/news-release-details/arrowhead-pharmaceuticals-participate-upcoming-may-2024 https://ir.arrowheadpharma.com/news-releases/news-release-details/arrowhead-pharmaceuticals-participate-upcoming-may-2024" [X Link](https://x.com/Longroaderstar/status/1784951096114569279) 2024-04-29T14:21Z [--] followers, [---] engagements "#inflation #xbi $SBUX $MCD Staples of American consumer BREAKING: Starbucks stock $SBUX extends its decline to -16% today hitting its lowest level since June [----]. The stock has now erased $35 BILLION in market cap since it hit its all time high in [----]. Globally Starbucks saw 6% decline in customer traffic in Q1 [----] ALONE. The https://t.co/4LPXy5FNQW BREAKING: Starbucks stock $SBUX extends its decline to -16% today hitting its lowest level since June [----]. The stock has now erased $35 BILLION in market cap since it hit its all time high in [----]. Globally Starbucks saw 6% decline in customer" [X Link](https://x.com/Longroaderstar/status/1785683936406024393) 2024-05-01T14:53Z [--] followers, [---] engagements "$prqr $lly .potential additional milestone income from existing partnership and potential option to exercise for expansion of deal to [--] targets. https://www.proqr.com/press-releases/proqr-announces-first-quarter-2024-operating-and-financial-results https://www.proqr.com/press-releases/proqr-announces-first-quarter-2024-operating-and-financial-results" [X Link](https://x.com/Longroaderstar/status/1788541194483716185) 2024-05-09T12:07Z [--] followers, [---] engagements "$otly $pton Oatly similar play to peloton. Private equity maybe a better option" [X Link](https://x.com/Longroaderstar/status/1788582430712213525) 2024-05-09T14:50Z [--] followers, [---] engagements "$NVDA Trading like insatiable demand for AI chips last forever. Tulips. Credit" [X Link](https://x.com/Longroaderstar/status/1795831658513662263) 2024-05-29T14:56Z [--] followers, [--] engagements "$arct $1.1b $mrna $57b $bntx $24.5b Cheapest $cvac $0.97b" [X Link](https://x.com/Longroaderstar/status/1797650913395605735) 2024-06-03T15:25Z [--] followers, [---] engagements "$LLY $NVO $VKTX Still think weight loss drugs are the answer 🚨10000 LAWSUITS HIT OZEMPIC WEGOVY AND MOUNJARO OVER SEVERE SIDE EFFECTS Ozempic and similar shots like Wegovy and Mounjaro are reportedly facing up to [-----] lawsuits from patients who claim the drugs caused debilitating side effects like stomach paralysis and 'tearing https://t.co/euJ0dI0686 🚨10000 LAWSUITS HIT OZEMPIC WEGOVY AND MOUNJARO OVER SEVERE SIDE EFFECTS Ozempic and similar shots like Wegovy and Mounjaro are reportedly facing up to [-----] lawsuits from patients who claim the drugs caused debilitating side effects like" [X Link](https://x.com/Longroaderstar/status/1801182403089858562) 2024-06-13T09:18Z [--] followers, [---] engagements "$cvac $bntx $mrna $pfe Get ready https://youtu.be/QGsM9IgVAJofeature=shared https://youtu.be/QGsM9IgVAJofeature=shared" [X Link](https://x.com/Longroaderstar/status/1802353524447302087) 2024-06-16T14:52Z [--] followers, [---] engagements "@mattyjc @TuckerBlows @BiotechAnalysst $SGMO $PFE Or rather than pay $250m milestone offer that to buy over the whole company. Its a good bargain" [X Link](https://x.com/Longroaderstar/status/1803062211545321829) 2024-06-18T13:48Z [--] followers, [---] engagements "#Bigtech #xbi When bigtech loses trillionaire status biotech will shine Market cap of Nvidia alone today is the entire size of Nasdaq during dotcom. A matter of time. Patience" [X Link](https://x.com/Longroaderstar/status/1803221912929312910) 2024-06-19T00:23Z [--] followers, [--] engagements "Short $NVDA and other Mag7 Long #Xbi $xbi Looks like a good trade heading into bubble deflation" [X Link](https://x.com/Longroaderstar/status/1805249914282352887) 2024-06-24T14:41Z [--] followers, [---] engagements "$PRQR $LLY better decide fast or watch Dicerna [---] @smarting1121 Roche has a huntingtin-repeat CAG-targeting RNAediting patent app with promising data. Maybe they'll buy $PRQR :). @smarting1121 Roche has a huntingtin-repeat CAG-targeting RNAediting patent app with promising data. Maybe they'll buy $PRQR :)" [X Link](https://x.com/Longroaderstar/status/1805968057380323493) 2024-06-26T14:15Z [--] followers, [---] engagements "$lly $morf Ok ATH is the asking now. https://www.prnewswire.com/news-releases/lilly-to-acquire-morphic-to-improve-outcomes-for-patients-with-inflammatory-bowel-disease-302190489.html https://www.prnewswire.com/news-releases/lilly-to-acquire-morphic-to-improve-outcomes-for-patients-with-inflammatory-bowel-disease-302190489.html" [X Link](https://x.com/Longroaderstar/status/1810268301693747359) 2024-07-08T11:02Z [--] followers, [--] engagements "$pfe $vktx Not buying $vktx or maybe a negotiation tactic https://www.businesswire.com/news/home/20240710971928/en/ https://www.businesswire.com/news/home/20240710971928/en/" [X Link](https://x.com/Longroaderstar/status/1811361157984502092) 2024-07-11T11:25Z [--] followers, [---] engagements "$SGMO Last [--] days either [--]. Shorts who have positioned for the big B probably covering or [--]. Deal/buyout/HemA readout is on the table. Likely both" [X Link](https://x.com/Longroaderstar/status/1811396756816761094) 2024-07-11T13:46Z [--] followers, [---] engagements "$prqr $mreo $arwr $adap $kron $achl $sgmo $cvac #xbi $xbi [---] Time for the microbots to steal the show Please do your own due diligence. Not investment advice" [X Link](https://x.com/Longroaderstar/status/1813209117789725040) 2024-07-16T13:48Z [--] followers, [----] engagements "$xbi #xbi IMO whether its Trump or Harris or anyone esle its gonna be one way ticket for the greatest bull XBI. Period. 150" [X Link](https://x.com/Longroaderstar/status/1815381172811399529) 2024-07-22T13:39Z [--] followers, [---] engagements "$SGMO $PFE Down to the wire [--] July. Its Pfizer's to call. $SGMO clock is clicking louder now that they are in 3Q. Recap of prior funding status statements https://t.co/bdyoX90uPa $SGMO clock is clicking louder now that they are in 3Q. Recap of prior funding status statements https://t.co/bdyoX90uPa" [X Link](https://x.com/Longroaderstar/status/1815668641075204318) 2024-07-23T08:41Z [--] followers, [----] engagements "$pfe $sgmo We look forward to advancing this latest innovation to help address the medical and treatment burden associated with frequent and time-consuming IV infusions or injections building on Pfizers more than 40-year effort to advance hemophilia treatment" [X Link](https://x.com/Longroaderstar/status/1816110314192265501) 2024-07-24T13:56Z [--] followers, [---] engagements "$adap No reason to sell patience. Fantastic platform attractive buyout candidate" [X Link](https://x.com/Longroaderstar/status/1819384611895759038) 2024-08-02T14:47Z [--] followers, [---] engagements "$prqr Gearing up to sig data release in next [--] months and milestone payment right on track from $LLY. https://www.proqr.com/press-releases/proqr-announces-second-quarter-2024-operating-and-financial-results https://www.proqr.com/press-releases/proqr-announces-second-quarter-2024-operating-and-financial-results" [X Link](https://x.com/Longroaderstar/status/1821560640911401099) 2024-08-08T14:54Z [--] followers, [---] engagements "$prqr Preclinical is hitting $1b for promising assets. Patience here for a nice buyout. https://www.biospace.com/novartis-buys-mariana-oncology-in-1b-acquisition-bolsters-radiopharma-assets https://www.biospace.com/novartis-buys-mariana-oncology-in-1b-acquisition-bolsters-radiopharma-assets" [X Link](https://x.com/Longroaderstar/status/1823874542726431028) 2024-08-15T00:09Z [--] followers, [---] engagements "@BiotechAnalysst $SGMO LOL if it shoots 20x someone should get fired" [X Link](https://x.com/Longroaderstar/status/1824760780199456836) 2024-08-17T10:50Z [--] followers, [---] engagements "$MREO Great run up waiting for partnership news. Matter of time" [X Link](https://x.com/Longroaderstar/status/1825566406794207630) 2024-08-19T16:12Z [--] followers, [---] engagements "$abus Will $mrna still have the funds to pay potential liabilities due to LNP patent lawsuits https://finance.yahoo.com/news/moderna-slashes-research-budget-vaccine-102233791.html https://finance.yahoo.com/news/moderna-slashes-research-budget-vaccine-102233791.html" [X Link](https://x.com/Longroaderstar/status/1834241602942108156) 2024-09-12T14:44Z [--] followers, [---] engagements "$pfe The decision is based on the totality of clinical data which now indicates that the benefit of Oxbryta no longer outweighs the risks associated with its use Pfizer said."fatal events" which require further assessment. https://www.reuters.com/business/healthcare-pharmaceuticals/pfizer-withdraws-sickle-cell-disease-treatment-all-markets-2024-09-25/taid=66f480efb3d88c00011e6185&utm_campaign=trueanthem&utm_medium=trueanthem&utm_source=twitter" [X Link](https://x.com/Longroaderstar/status/1839085822974505015) 2024-09-25T23:33Z [--] followers, [---] engagements "$sgmo $pfe No surprise if Pfizer or another BP comes here. $SGMO says [--] patients data on new manufacturing drug in #sickle #cell looks as good as rest out the ie $CRSP = all 45%+ looking to partner $SGMO says [--] patients data on new manufacturing drug in #sickle #cell looks as good as rest out the ie $CRSP = all 45%+ looking to partner" [X Link](https://x.com/Longroaderstar/status/1839185066800590967) 2024-09-26T06:07Z [--] followers, [---] engagements "$sgmo What a mess Zinc Fingers. Patently clear. https://www.technologyreview.com/2024/09/25/1104475/nobel-prize-winners-cancel-crispr-patents-europe/ https://www.technologyreview.com/2024/09/25/1104475/nobel-prize-winners-cancel-crispr-patents-europe/" [X Link](https://x.com/Longroaderstar/status/1839232274421920158) 2024-09-26T09:15Z [--] followers, [---] engagements "#xbi $xbi Fed rate cuts + soft landing = boom time biotech" [X Link](https://x.com/Longroaderstar/status/1842356008854995125) 2024-10-05T00:07Z [--] followers, [--] engagements "$pfe $sgmo Triple combo" [X Link](https://x.com/Longroaderstar/status/1846053352238649567) 2024-10-15T04:59Z [--] followers, [---] engagements "@RNAiAnalyst @BioMan944918473 My healthy worry is they get bought out early at $3b in [----]. Its worth $30b for next few years. Not far fetch considering how hot the gene editing craze was in [----] and with lower interest rates. $prqr" [X Link](https://x.com/Longroaderstar/status/1847945407923692024) 2024-10-20T10:18Z [---] followers, [---] engagements "$PRQR $WVE $KRRO #RNA #RNAediting 1/8 With latest proof of mechanism (POM) of RNA editing in AATD human patients by $WVE here's why this field is going to dominate next year's biotech boom and why ProQR is the next big tech in this field" [X Link](https://x.com/Longroaderstar/status/1848665717404475747) 2024-10-22T10:00Z [--] followers, [---] engagements "2/8 Interest in RNA editing is only going to accelerate next year. Big pharma with the likes of Eli Lily GSK Novo Nordisk and Roche have already invested billions. More to come. See excellent article by Gerald Platenburg (ProQr). https://www.biospace.com/interest-in-rna-editing-accelerates-as-therapies-approach-the-clinic https://www.biospace.com/interest-in-rna-editing-accelerates-as-therapies-approach-the-clinic" [X Link](https://x.com/Longroaderstar/status/1848665719246135296) 2024-10-22T10:00Z [--] followers, [---] engagements "7/8 ProQR has the smallest market cap of $330m compared to Korro ($705m) and Wave ($2.2b) despite having pioneered the RNA editing field owns key patents differentiated pipeline and a giant partner (Eli Lily)" [X Link](https://x.com/Longroaderstar/status/1848665736237223982) 2024-10-22T10:00Z [--] followers, [---] engagements "8/8 Key catalysts for ProQR: preclinical data for IND in 4Q especially AX-1412 additional $50m by Lily for [--] more targets unveil on Lily targets new partnerships relatively quick trial results with healthy volunteers for POM (dyodd not investment advice)" [X Link](https://x.com/Longroaderstar/status/1848665739399667898) 2024-10-22T10:00Z [--] followers, [---] engagements "$SGMO Ridiculous this is still at tiny mkt cap of $300m and below $5 HemA P3 readout supports BLA milestone payment $220m incoming and royalties $1.9b deal with Genetech Fabry accelerated approval BLA [----] billion dollar market STAC-BBB prion MINT etc" [X Link](https://x.com/Longroaderstar/status/1848736715760144737) 2024-10-22T14:42Z [---] followers, [----] engagements "$prqr This should be priced above $3.5 possibly $50m with option 15% more. Funds seeking to enter. Next pl switch to Nasdaq direct listing. https://www.proqr.com/press-releases/proqr-announces-proposed-underwritten-public-offering-of-ordinary-shares https://www.proqr.com/press-releases/proqr-announces-proposed-underwritten-public-offering-of-ordinary-shares" [X Link](https://x.com/Longroaderstar/status/1848891010304331945) 2024-10-23T00:55Z [---] followers, [---] engagements "@RNAiAnalyst $prqr Demand is strong like recent Wave offering at $8 which now close to doubled. No surprise here" [X Link](https://x.com/Longroaderstar/status/1848974622806708573) 2024-10-23T06:27Z [--] followers, [---] engagements "#xbi $xbi $sgmo $prqr $mreo $arwr $vtyx $kron and others I dont discuss politics but if Trump wins in less than [--] weeks it is going to be incredibly bullish for biotech stocks Drill baby drill (oil) Cut baby cut (rates)" [X Link](https://x.com/Longroaderstar/status/1849830160146759989) 2024-10-25T15:07Z [--] followers, [----] engagements "$PRQR Nice end to the week cashed-up at $3.50 with $LLY as great partner. Feels like next few months entering clinic is going to be very significant here for the leader of this field. @ProQR #RNAediting 8/8 Key catalysts for ProQR: preclinical data for IND in 4Q especially AX-1412 additional $50m by Lily for [--] more targets unveil on Lily targets new partnerships relatively quick trial results with healthy volunteers for POM (dyodd not investment advice) 8/8 Key catalysts for ProQR: preclinical data for IND in 4Q especially AX-1412 additional $50m by Lily for [--] more targets unveil on Lily" [X Link](https://x.com/Longroaderstar/status/1850083593940602938) 2024-10-26T07:54Z [---] followers, [----] engagements "$SGMO Maintaining full position zero traded. Positive signs: No offering despite increase in stock price 167% ytd. Options market suggest huge movement soon Two late stage drugs (hemA/Fabry) maybe target of buyout Extremely undervalued at $311m mkt cap. $SGMO Ridiculous this is still at tiny mkt cap of $300m and below $5 HemA P3 readout supports BLA milestone payment $220m incoming and royalties $1.9b deal with Genetech Fabry accelerated approval BLA [----] billion dollar market STAC-BBB prion MINT etc $SGMO Ridiculous this is still at tiny mkt cap of $300m and below $5 HemA P3 readout supports" [X Link](https://x.com/Longroaderstar/status/1850086692184826127) 2024-10-26T08:06Z [---] followers, [----] engagements "@BiotechAnalysst $sgmo A generational investment opportunity only happens a few times in your lifetime. REGENERON NVIDA NETFLIX MONSTER BEVERAGE.100X baggers This COULD be one of them" [X Link](https://x.com/Longroaderstar/status/1850852779969118421) 2024-10-28T10:51Z [---] followers, [---] engagements "$sgmo Looks like STAC-BBB is worth a lot more now. https://www.prnewswire.com/news-releases/abbvie-to-acquire-aliada-therapeutics-strengthening-focus-in-alzheimers-disease-and-neuroscience-pipeline-302288180.html https://www.prnewswire.com/news-releases/abbvie-to-acquire-aliada-therapeutics-strengthening-focus-in-alzheimers-disease-and-neuroscience-pipeline-302288180.html" [X Link](https://x.com/Longroaderstar/status/1850929554824867915) 2024-10-28T15:56Z [---] followers, [----] engagements "@mchilberg After Abbvie and Roche news chances are the next poker card dealt is the one Sandy and the board chose. Or Fabry. The market realises. $SGMO" [X Link](https://x.com/Longroaderstar/status/1851190384996860311) 2024-10-29T09:12Z [---] followers, [---] engagements "@RNAiAnalyst Agree. $Vir is best in class in knockdowns so far in the HBV/HDV space compared to GSK and ABUS. GILD may make a move once they see enough data" [X Link](https://x.com/Longroaderstar/status/1852148822191051011) 2024-11-01T00:41Z [--] followers, [---] engagements "#XBI $xbi Futures for the small cap benchmark Russell [----] also a projected Trump beneficiary jumped 5%. https://www.cnbc.com/2024/11/05/stock-market-today-live-updates.html https://www.cnbc.com/2024/11/05/stock-market-today-live-updates.html" [X Link](https://x.com/Longroaderstar/status/1854084210224701646) 2024-11-06T08:51Z [--] followers, [--] engagements "#xbi $xbi $sgmo $prqr $mreo $arwr $vtyx $kron and others Lets get to $xbi [---] #xbi $xbi $sgmo $prqr $mreo $arwr $vtyx $kron and others I dont discuss politics but if Trump wins in less than [--] weeks it is going to be incredibly bullish for biotech stocks Drill baby drill (oil) Cut baby cut (rates) #xbi $xbi $sgmo $prqr $mreo $arwr $vtyx $kron and others I dont discuss politics but if Trump wins in less than [--] weeks it is going to be incredibly bullish for biotech stocks Drill baby drill (oil) Cut baby cut (rates)" [X Link](https://x.com/Longroaderstar/status/1854160148115460135) 2024-11-06T13:53Z [--] followers, [----] engagements "$sgmo Better than owning shitcoins like dodge coin with $60b marketcap. Next deal will happen. Its a matter of the right price and partner. Watching for any pipe deal or ATM sale none will be the best signal a deal is close. Ask yourself: is this pipeline worth $158m That is the current market capitalization of $SGMO https://t.co/ppRj29AC7X Ask yourself: is this pipeline worth $158m That is the current market capitalization of $SGMO https://t.co/ppRj29AC7X" [X Link](https://x.com/Longroaderstar/status/1856324078346612886) 2024-11-12T13:12Z [--] followers, [----] engagements "$sgmo $pfe Pfizer just made $4.4b for 3Q. And they are set to dominate the market for Hem A ($sgmo P3) and Hem B (Beqvez FDA approved in 2024). Hem A is [--] times more prevalent than Hem B. Anyone who thinks Pfizer walks away is delusional. Its reputational suicide as well" [X Link](https://x.com/Longroaderstar/status/1856715613596692708) 2024-11-13T15:07Z [--] followers, [----] engagements "$sgmo Healthy pull back from some speculative rumor of a Fabry deal in 3Q. Patience. Add to that RFK nomination and $xbi down 3%. After all the rhetoric is gone we still need cures for rare diseases and brain diseases. The people want quick approvals" [X Link](https://x.com/Longroaderstar/status/1857255527694352451) 2024-11-15T02:53Z [--] followers, [---] engagements "@PirateWaffle $kron Had wished 80mg works this would had 2x or 3x. Now gotta settle for 1x. Not too bad either. Its Nobert's call" [X Link](https://x.com/Longroaderstar/status/1857469225977459000) 2024-11-15T17:02Z [--] followers, [---] engagements "$arwr Great milestone Today we announced the submission of a New Drug Application (NDA) to the @US_FDA for our investigational #RNAi medicine for treatment of familial chylomicronemia syndrome (#FCS). We plan to submit applications for approval in [----]. Learn more: https://t.co/ycDYFhDUPC $ARWR https://t.co/36Sa568KwN Today we announced the submission of a New Drug Application (NDA) to the @US_FDA for our investigational #RNAi medicine for treatment of familial chylomicronemia syndrome (#FCS). We plan to submit applications for approval in [----]. Learn more: https://t.co/ycDYFhDUPC $ARWR" [X Link](https://x.com/Longroaderstar/status/1858722439603384709) 2024-11-19T04:02Z [--] followers, [---] engagements "$VIR HDV Phase [--] in [----] HBV Functional cure readout in Q2 Negative EV : @Vir_Biotech presented data from programs for chronic hepatitis B and chronic hepatitis delta at #TLM24. $VIR Full video: https://t.co/bhfORL2FHG https://t.co/6HaTPvvkfV : @Vir_Biotech presented data from programs for chronic hepatitis B and chronic hepatitis delta at #TLM24. $VIR Full video: https://t.co/bhfORL2FHG https://t.co/6HaTPvvkfV" [X Link](https://x.com/Longroaderstar/status/1859987947543789964) 2024-11-22T15:50Z [--] followers, [---] engagements "$prqr $lly Will Eli Lily acquire ProQr Already own 16.4%. #xbi $xbi $pstx Wow keep it flowing. $1.5b. Roche has seen enough to acquire the whole outfit. Was a [----] partnership $110m upfront $6b aggregate deal. https://t.co/P9RXeXOCII #xbi $xbi $pstx Wow keep it flowing. $1.5b. Roche has seen enough to acquire the whole outfit. Was a [----] partnership $110m upfront $6b aggregate deal. https://t.co/P9RXeXOCII" [X Link](https://x.com/Longroaderstar/status/1861322106224681107) 2024-11-26T08:12Z [--] followers, [----] engagements "$sgmo $pfe Will Pfizer acquire Sangamo Or Genentech #xbi $xbi $pstx Wow keep it flowing. $1.5b. Roche has seen enough to acquire the whole outfit. Was a [----] partnership $110m upfront $6b aggregate deal. https://t.co/P9RXeXOCII #xbi $xbi $pstx Wow keep it flowing. $1.5b. Roche has seen enough to acquire the whole outfit. Was a [----] partnership $110m upfront $6b aggregate deal. https://t.co/P9RXeXOCII" [X Link](https://x.com/Longroaderstar/status/1861322656920019295) 2024-11-26T08:14Z [--] followers, [---] engagements "$arwr Another deal Cash $825m immediate. Wow. https://ir.arrowheadpharma.com/news-releases/news-release-details/arrowhead-pharmaceuticals-announces-global-license-and https://ir.arrowheadpharma.com/news-releases/news-release-details/arrowhead-pharmaceuticals-announces-global-license-and" [X Link](https://x.com/Longroaderstar/status/1861393164722147560) 2024-11-26T12:54Z [--] followers, [---] engagements "$VIR #hdv #hbv GILEAD or GSK may be eyeing this. Best in class HDV and HBV. Pharmasset was acquired by Gilead in P3 for $11b in [----]. $VIR HDV Phase [--] in [----] HBV Functional cure readout in Q2 Negative EV $VIR HDV Phase [--] in [----] HBV Functional cure readout in Q2 Negative EV" [X Link](https://x.com/Longroaderstar/status/1861438645036818726) 2024-11-26T15:55Z [--] followers, [---] engagements "@RNAiAnalyst $arwr Such an underwhelming response today. BP could snatch it away while its still cheap. $80 is possible" [X Link](https://x.com/Longroaderstar/status/1861593584069447881) 2024-11-27T02:11Z [--] followers, [---] engagements "$ARWR $SRPT equity at $27.25. Shorts holding it down to unwind yesterday. Good let it rip now. Its a buyout target. Cash till 2028" [X Link](https://x.com/Longroaderstar/status/1861784919124713826) 2024-11-27T14:51Z [--] followers, [---] engagements "$SGMO $PTCT $1b upfront. Wow. If Takeda doesnt match up here another partner will step up. https://ir.ptcbio.com/news-releases/news-release-details/ptc-therapeutics-enters-global-license-and-collaboration Suppression of #Huntingtons Disease Somatic Instability by Transcriptional Repression and Direct CAG Repeat Binding $SGMO "we believe that #epigenetic #editing techniques such as #ZFPs have great theoretical #advantages as therapies for HD " https://t.co/DcryANPRJg https://ir.ptcbio.com/news-releases/news-release-details/ptc-therapeutics-enters-global-license-and-collaboration Suppression of" [X Link](https://x.com/Longroaderstar/status/1863560060305289321) 2024-12-02T12:25Z [--] followers, [----] engagements "$arwr There it is Today we announced we have filed a request for regulatory clearance to initiate a Phase 1/2a Study of ARO-ALK7 our second #RNAi therapy being developed as a potential treatment for obesity. Read more in our press release: https://t.co/2eLfp7Z2Ey https://t.co/wif8sOS0zG Today we announced we have filed a request for regulatory clearance to initiate a Phase 1/2a Study of ARO-ALK7 our second #RNAi therapy being developed as a potential treatment for obesity. Read more in our press release: https://t.co/2eLfp7Z2Ey https://t.co/wif8sOS0zG" [X Link](https://x.com/Longroaderstar/status/1864256312319856791) 2024-12-04T10:31Z [--] followers, [---] engagements "$sgmo Nicely forming a cup and handle. $pfe ASH [--] Dec and BLA is close" [X Link](https://x.com/Longroaderstar/status/1864682551857860612) 2024-12-05T14:45Z [--] followers, [---] engagements "$sgmo 1/3 Anyone fixated on cash runway. Prob $70m tied to BLA filing. https://www.investing.com/news/stock-market-news/earnings-call-sangamo-therapeutics-extends-cash-runway-into-2025-93CH-3560133 https://www.investing.com/news/stock-market-news/earnings-call-sangamo-therapeutics-extends-cash-runway-into-2025-93CH-3560133" [X Link](https://x.com/Longroaderstar/status/1864949753508958326) 2024-12-06T08:27Z [--] followers, [---] engagements "$prqr $lly Time to peel the wool away from the market. @RNAiAnalyst $prqr [--] years here too. Expects news before they enter clinical Q4. https://t.co/QcooMxjM01 @RNAiAnalyst $prqr [--] years here too. Expects news before they enter clinical Q4. https://t.co/QcooMxjM01" [X Link](https://x.com/Longroaderstar/status/1865060079755825235) 2024-12-06T15:45Z [--] followers, [---] engagements "$VIR Tcell event a side show. HDV and HBV is the $10b main event. $VIR #hdv #hbv GILEAD or GSK may be eyeing this. Best in class HDV and HBV. Pharmasset was acquired by Gilead in P3 for $11b in [----]. $VIR #hdv #hbv GILEAD or GSK may be eyeing this. Best in class HDV and HBV. Pharmasset was acquired by Gilead in P3 for $11b in 2011" [X Link](https://x.com/Longroaderstar/status/1865192370054271243) 2024-12-07T00:31Z [--] followers, [---] engagements "$arwr ARO-ALK7 next https://ir.bioagelabs.com/news-releases/news-release-details/bioage-labs-announces-discontinuation-strides-phase-2-clinical https://ir.bioagelabs.com/news-releases/news-release-details/bioage-labs-announces-discontinuation-strides-phase-2-clinical" [X Link](https://x.com/Longroaderstar/status/1865193540206366930) 2024-12-07T00:36Z [--] followers, [---] engagements "#xbi $xbi #COVID19 Here we go again. WHO deploys a team of experts to Congo to help investigate mysterious disease https://t.co/vsWZAJ7TCa WHO deploys a team of experts to Congo to help investigate mysterious disease https://t.co/vsWZAJ7TCa" [X Link](https://x.com/Longroaderstar/status/1865267632938914173) 2024-12-07T05:30Z [--] followers, [--] engagements "@Biotech2050 $sgmo $pfe They will complete the hemophilia franchise without a doubt" [X Link](https://x.com/Longroaderstar/status/1865970571743506613) 2024-12-09T04:03Z [--] followers, [----] engagements "$sgmo $pfe Estimate BLA Jan25 around inauguration and PDUFA July25 with priority review. Best in class treatment. Were excited for @pfizer #ASH2024 oral presentation today showcasing data from Ph.3 AFFINE trial of giroctocogene fitelparvovec a gene therapy that we co-developed with and licensed to PFE for the treatment of adults w/moderately severe to severe Hem A. https://t.co/Zj9sdsDcg7 Were excited for @pfizer #ASH2024 oral presentation today showcasing data from Ph.3 AFFINE trial of giroctocogene fitelparvovec a gene therapy that we co-developed with and licensed to PFE for the treatment" [X Link](https://x.com/Longroaderstar/status/1866260166355866071) 2024-12-09T23:14Z [--] followers, [----] engagements "@RNAiAnalyst $sgmo $mgx Perhaps as 2nd gen HemA gene Tx but IND filing [----] and BLA maybe [----]. Means no other shots come close to giroctocogene fitelparvovec for at least the next [--] years" [X Link](https://x.com/Longroaderstar/status/1866447485910343922) 2024-12-10T11:38Z [--] followers, [---] engagements "@RNAiAnalyst @stonkgang Surprised $arwr not in Top [--]. Cheap and cashed up" [X Link](https://x.com/Longroaderstar/status/1866483581587243050) 2024-12-10T14:02Z [--] followers, [---] engagements "$rvph More than doubled since last entry price. Data drop anytime now" [X Link](https://x.com/Longroaderstar/status/1866892519075917971) 2024-12-11T17:07Z [--] followers, [---] engagements "$SGMO $PFE [--] Dec. Drop some Christmas nuggets here. https://investors.pfizer.com/Investors/News/news-details/2024/Pfizer-Invites-Public-to-View-and-Listen-to-Webcast-of-December-17-Conference-Call-with-Analysts-to-Provide-Full-Year-2025-Financial-Guidance/default.aspx https://investors.pfizer.com/Investors/News/news-details/2024/Pfizer-Invites-Public-to-View-and-Listen-to-Webcast-of-December-17-Conference-Call-with-Analysts-to-Provide-Full-Year-2025-Financial-Guidance/default.aspx" [X Link](https://x.com/Longroaderstar/status/1867230133297569940) 2024-12-12T15:28Z [--] followers, [----] engagements "$prqr Good investor meeting laying out next [--] years with multiple clinical readouts can sense strong hints of new partnerships. Expect the pipeline to grow into a multi-billion powerhouse next few years" [X Link](https://x.com/Longroaderstar/status/1867232837424025859) 2024-12-12T15:39Z [--] followers, [----] engagements "$rvph May close above $3 today. Mcap below $100m. If they can show good set of data its going parabolic" [X Link](https://x.com/Longroaderstar/status/1867235720915759223) 2024-12-12T15:51Z [--] followers, [---] engagements "$sgmo $pfe Will Pfizer fast track BLA submission for giroctocogene fitelparvovec before the new Administration takes over If so Dec is possible. $sgmo $pfe Estimate BLA Jan25 around inauguration and PDUFA July25 with priority review. Best in class treatment. $sgmo $pfe Estimate BLA Jan25 around inauguration and PDUFA July25 with priority review. Best in class treatment" [X Link](https://x.com/Longroaderstar/status/1867591457479299088) 2024-12-13T15:24Z [--] followers, [---] engagements "$prqr Another crazy $xbi selloff day gene editing stocks slammed.RNA too. LOL. Patience here" [X Link](https://x.com/Longroaderstar/status/1867613030437335063) 2024-12-13T16:50Z [--] followers, [---] engagements "#NASDAQ #bullrun #BearBull This probably tops the market. Super bearish. BREAKING: MicroStrategy $MSTR is joining the Nasdaq [---] index. https://t.co/nKEYPkAs1m BREAKING: MicroStrategy $MSTR is joining the Nasdaq [---] index. https://t.co/nKEYPkAs1m" [X Link](https://x.com/Longroaderstar/status/1867748509807776138) 2024-12-14T01:48Z [--] followers, [---] engagements "#xbi $xbi OTOH this touches the bottom for biotech. Pendulum swing always corrects. #NASDAQ #bullrun #BearBull This probably tops the market. Super bearish. #NASDAQ #bullrun #BearBull This probably tops the market. Super bearish" [X Link](https://x.com/Longroaderstar/status/1867751178546950301) 2024-12-14T01:59Z [--] followers, [---] engagements "$SGMO Market finally believes $PFE is filing BLA when Roche drops HemA. Sandy mentioned cash issue will be solved in this way. They can negotiate Fabry STAC-BBB MINT Tregs Prion new CNS targets.all now in a position of strength. Sit back and enjoy the rocket up" [X Link](https://x.com/Longroaderstar/status/1868681659937374431) 2024-12-16T15:36Z [--] followers, [----] engagements "@RNAiAnalyst $prqr In that case even more so they should diversify away from $LLY. There might be a tussle with other BP on target areas and partnerships. $REGN" [X Link](https://x.com/Longroaderstar/status/1868699455350095940) 2024-12-16T16:47Z [--] followers, [----] engagements "$BIOAB up 32% $1.2b mkt cap. (STO) $SGMO STAC-BBB can surely do better with Genentech and Astellas endorsement. https://www.bioarctic.com/en/bioarctic-announces-global-license-agreement-with-bristol-myers-squibb-for-bioarctics-pyroglutamate-amyloid-beta-antibody-program/ https://www.bioarctic.com/en/bioarctic-announces-global-license-agreement-with-bristol-myers-squibb-for-bioarctics-pyroglutamate-amyloid-beta-antibody-program/" [X Link](https://x.com/Longroaderstar/status/1869753316072403043) 2024-12-19T14:35Z [---] followers, [---] engagements "$NVO $LLY $VKTX Weight loss 22.7% after [--] weeks not way off 25%. Sell on news.as always. $xbi is sick. https://www.statnews.com/2024/12/20/novo-nordisk-cagrisema-obesity-wegovy/ https://www.statnews.com/2024/12/20/novo-nordisk-cagrisema-obesity-wegovy/" [X Link](https://x.com/Longroaderstar/status/1870091548685455654) 2024-12-20T12:59Z [--] followers, [---] engagements "$xbi Reload calls. History will be made today: As the Nasdaq is down over -6% from its high in just [--] days there are a MASSIVE amount of options expiring today. In fact a record $6.6 TRILLION worth of options are expiring based on notional value. What does this mean exactly (a thread) History will be made today: As the Nasdaq is down over -6% from its high in just [--] days there are a MASSIVE amount of options expiring today. In fact a record $6.6 TRILLION worth of options are expiring based on notional value. What does this mean exactly (a thread)" [X Link](https://x.com/Longroaderstar/status/1870118185422467277) 2024-12-20T14:44Z [--] followers, [--] engagements "@auditor112017 @mchilberg $SGMO Astellas probably saw good signals fr Aviado ph1 trial (FTD-GRN) via AVB-101 (AAV9) cohort fully dosed by Oct24. Next logical step is to use STAC-BBB to CNS. 700x" [X Link](https://x.com/Longroaderstar/status/1870351991358341201) 2024-12-21T06:13Z [--] followers, [---] engagements "$ARWR This may be the dark horse in obesity race.and comes with an impressive late stage pipeline. One of [----] top bet. https://arrowheadpharma.com/news-press/arrowhead-pharmaceuticals-initiates-phase-1-2a-study-of-aro-inhbe-for-the-treatment-of-obesity/ https://arrowheadpharma.com/news-press/arrowhead-pharmaceuticals-initiates-phase-1-2a-study-of-aro-inhbe-for-the-treatment-of-obesity/" [X Link](https://x.com/Longroaderstar/status/1871200161734721681) 2024-12-23T14:24Z [--] followers, [---] engagements "#H5N1 #xbi $xbi Next pandemic https://www.statnews.com/2024/12/26/cdc-says-h5n1-bird-flu-sample-shows-mutations-that-may-help-the-virus-bind-to-cells-in-the-upper-airways-of-people/ https://www.statnews.com/2024/12/26/cdc-says-h5n1-bird-flu-sample-shows-mutations-that-may-help-the-virus-bind-to-cells-in-the-upper-airways-of-people/" [X Link](https://x.com/Longroaderstar/status/1872618238699577653) 2024-12-27T12:19Z [--] followers, [---] engagements "$SGMO $PFE Market reaction will be severe investors in for wild ride. Pfizer is well known for dumb decisions. After [--] years and this. STAC-BBB is still in the money Fabry deal is advanced. Focus on the positives for 2025" [X Link](https://x.com/Longroaderstar/status/1873912757734740442) 2024-12-31T02:03Z [--] followers, [----] engagements "@RNAiAnalyst My guess also to protect recurring HEMLIBRA and HYMPAVZI revenues. $sgmo $pfe" [X Link](https://x.com/Longroaderstar/status/1874003857673773346) 2024-12-31T08:05Z [--] followers, [---] engagements "@Franca_ole @JungleJorge2 @sampetherick Was abandoned for dead but revived because of its science. Its new neuro direction is the future. Not HemA. Not pfizer" [X Link](https://x.com/Longroaderstar/status/1874023283445948533) 2024-12-31T09:22Z [--] followers, [---] engagements "$VIR Events to look out for: [--] Jan - T cell engager virtual event [--] Jan - JP Morgan presentation" [X Link](https://x.com/Longroaderstar/status/1874114573114220614) 2024-12-31T15:25Z [--] followers, [---] engagements "#xbi $xbi To be an inter-planetary species we need to be genetically remodelled. [----] bios will shine. Peace. Patience" [X Link](https://x.com/Longroaderstar/status/1874272198619521260) 2025-01-01T01:51Z [--] followers, [---] engagements "@davidycli $xbi #GeneTherapy @elonmusk USA must not lose to China in biotech research and in particular DNA/RNA editing" [X Link](https://x.com/Longroaderstar/status/1874830431297929260) 2025-01-02T14:49Z [--] followers, [---] engagements "$xbi Good start to [----] Xbi 150" [X Link](https://x.com/Longroaderstar/status/1874857596550852885) 2025-01-02T16:37Z [--] followers, [--] engagements "@RNAiAnalyst $VIR #HBV Functional cure readout in Q2. May be sold by then" [X Link](https://x.com/Longroaderstar/status/1877002347269742997) 2025-01-08T14:40Z [--] followers, [---] engagements "$ARWR No JPM presentation despite all the clinical good news and BD. Blackout" [X Link](https://x.com/Longroaderstar/status/1877003299280273900) 2025-01-08T14:43Z [--] followers, [---] engagements "$NTLA $EDIT $CRSP $BEAM GT decimated over past few years cash burn low investor sentiment. What can turn it around https://www.globenewswire.com/news-release/2025/01/09/3007346/0/en/Intellia-Therapeutics-Announces-Anticipated-2025-Milestones-and-Strategic-Reorganization-to-Prioritize-the-Advancement-of-its-Late-Stage-Programs-NTLA-2002-and-Nexiguran-Ziclumeran.html" [X Link](https://x.com/Longroaderstar/status/1877571703506874821) 2025-01-10T04:22Z [--] followers, [----] engagements "$GSK Good omen for the year unicorn deal. https://www.businesswire.com/news/home/20250112698434/en/GSK-Enters-Agreement-to-Acquire-IDRx-Inc https://www.businesswire.com/news/home/20250112698434/en/GSK-Enters-Agreement-to-Acquire-IDRx-Inc" [X Link](https://x.com/Longroaderstar/status/1878721159203877064) 2025-01-13T08:30Z [--] followers, [--] engagements "$MREO Sold significantly before 1st interim readout.key risk was overly high hopes on 1st. https://www.mereobiopharma.com/news-and-events/news/update-on-lead-clinical-programs/ https://www.mereobiopharma.com/news-and-events/news/update-on-lead-clinical-programs/" [X Link](https://x.com/Longroaderstar/status/1878734731724165437) 2025-01-13T09:23Z [--] followers, [---] engagements "$LLY $VKTX $NVO Weight-loss getting slammed. Already warned its too crowded. https://www.bloomberg.com/news/articles/2025-01-14/lilly-2024-sales-miss-estimate-as-weight-loss-drugs-slowsrnd=homepage-asia https://www.bloomberg.com/news/articles/2025-01-14/lilly-2024-sales-miss-estimate-as-weight-loss-drugs-slowsrnd=homepage-asia" [X Link](https://x.com/Longroaderstar/status/1879179608261845340) 2025-01-14T14:51Z [--] followers, [---] engagements "#xbi $xbi The term Colossal failure sounds more familiar. Colossal Biosciences raises $200M at $10.2B valuation to bring back woolly mammoths https://t.co/uonkg29Z7s Colossal Biosciences raises $200M at $10.2B valuation to bring back woolly mammoths https://t.co/uonkg29Z7s" [X Link](https://x.com/Longroaderstar/status/1880204582846099818) 2025-01-17T10:44Z [--] followers, [--] engagements "$ARWR Nice. The FDA provided a Prescription Drug User Fee Act (PDUFA) action date ofNovember [--] [----] https://ir.arrowheadpharma.com/news-releases/news-release-details/arrowhead-pharmaceuticals-announces-acceptance-new-drug https://ir.arrowheadpharma.com/news-releases/news-release-details/arrowhead-pharmaceuticals-announces-acceptance-new-drug" [X Link](https://x.com/Longroaderstar/status/1880462527701873122) 2025-01-18T03:49Z [--] followers, [---] engagements "#xbi $xbi Vibes from new Administration seems very good so far lower interest rates cancer vaccines AI in biotech less regulation gene editing Xbi [---] 🚀" [X Link](https://x.com/Longroaderstar/status/1882800240190996863) 2025-01-24T14:38Z [--] followers, [---] engagements "@mchilberg $sgmo Great observation. Astellas seems to be playing catch up with Roche again $pstx. Maybe this time is different" [X Link](https://x.com/Longroaderstar/status/1882963240181014788) 2025-01-25T01:26Z [---] followers, [---] engagements "$prqr Trading like $wve proof of concept never happened and placement at $3.50 as well. One of my Gems in Bio wasteland. LOL" [X Link](https://x.com/Longroaderstar/status/1884889825578504391) 2025-01-30T09:02Z [---] followers, [----] engagements "$PRQR AAV gene therapy approach to Rett Syndrome $TSHA Estimated 750k sufferers worldwide USA 30k. https://seekingalpha.com/article/4752344-taysha-gene-therapies-is-showing-promise-for-rett-syndrome https://seekingalpha.com/article/4752344-taysha-gene-therapies-is-showing-promise-for-rett-syndrome" [X Link](https://x.com/Longroaderstar/status/1885156277405499475) 2025-01-31T02:40Z [---] followers, [---] engagements "$sgmo $vygr Payload failure not capsid. https://www.globenewswire.com/news-release/2025/02/11/3024034/36461/en/Voyager-Provides-Update-on-SOD1-ALS-Gene-Therapy-Program.html https://www.globenewswire.com/news-release/2025/02/11/3024034/36461/en/Voyager-Provides-Update-on-SOD1-ALS-Gene-Therapy-Program.html" [X Link](https://x.com/Longroaderstar/status/1889318378600529941) 2025-02-11T14:19Z [---] followers, [----] engagements "$xbi #xbi Look past the current figures. Its already falling. *HASSETT: WE WILL FIX INFLATION WITH OR WITHOUT THE FED *HASSETT: WE WILL FIX INFLATION WITH OR WITHOUT THE FED" [X Link](https://x.com/Longroaderstar/status/1889690717158584805) 2025-02-12T14:59Z [--] followers, [---] engagements "$PRQR ADAGE Capital 9.3% stake now. Wow https://www.sec.gov/Archives/edgar/data/1535978/000090266425000880/xslSCHEDULE_13G_X01/primary_doc.xml https://www.sec.gov/Archives/edgar/data/1535978/000090266425000880/xslSCHEDULE_13G_X01/primary_doc.xml" [X Link](https://x.com/Longroaderstar/status/1890352307138621939) 2025-02-14T10:48Z [---] followers, [---] engagements "$SGMO Buyout monday trade again. Nice bounce off lows. This time may be real" [X Link](https://x.com/Longroaderstar/status/1895501545833468065) 2025-02-28T15:49Z [---] followers, [----] engagements "@ZinselmeyerB $SGMO Insiders loaded with options not far from current price. Thats a great signal. This is a GT powerhouse with a great neuro future with Astellas and Genetech. Not SKYPE" [X Link](https://x.com/Longroaderstar/status/1895507533424669126) 2025-02-28T16:13Z [---] followers, [---] engagements "$prqr Wow back to negative EV again. Flush out stop losses again before earnings. Earning release in a week last year [--] March" [X Link](https://x.com/Longroaderstar/status/1897669456983412929) 2025-03-06T15:23Z [---] followers, [---] engagements "$tsvt Next $adap https://www.businesswire.com/news/home/20250310482749/en/2seventy-bio-Enters-into-Definitive-Agreement-to-be-Acquired-by-Bristol-Myers-Squibb https://www.businesswire.com/news/home/20250310482749/en/2seventy-bio-Enters-into-Definitive-Agreement-to-be-Acquired-by-Bristol-Myers-Squibb" [X Link](https://x.com/Longroaderstar/status/1899291636221583614) 2025-03-11T02:49Z [---] followers, [---] engagements "$SGMO Why would they announce a deal here at Barclays Not the right platform and timing. Listen in for nuggets from Sandy" [X Link](https://x.com/Longroaderstar/status/1899848374054207846) 2025-03-12T15:42Z [---] followers, [---] engagements "$mgtx $sgmo Neuro and CNS delivery is confirmed next big area after obesity. $200m upfront here. Roche or Astellas will come for STAC-BBB and the whole suite. https://investors.meiragtx.com/news-releases/news-release-details/meiragtx-enters-strategic-collaboration-hologen-ai-expedite https://investors.meiragtx.com/news-releases/news-release-details/meiragtx-enters-strategic-collaboration-hologen-ai-expedite" [X Link](https://x.com/Longroaderstar/status/1900158265155322174) 2025-03-13T12:13Z [---] followers, [---] engagements "$prqr 1/2 Mcap $184m mid [----]. -EV [--] key items [----] AX-0810 CTA mid-yr readout year-end AX-1412 mid-yr optimization for GalNAc delivery https://www.proqr.com/press-releases/proqr-announces-year-end-2024-operating-and-financial-results https://www.proqr.com/press-releases/proqr-announces-year-end-2024-operating-and-financial-results" [X Link](https://x.com/Longroaderstar/status/1900388337866731979) 2025-03-14T03:27Z [---] followers, [---] engagements "$sgmo Having a Monday earnings release means they are putting final ink to a deal and wants to seal it. If terms dont work then prob a $20m to $30m financing to tide over till the big deals $200m land. Similar to a year ago. Take advantage of it" [X Link](https://x.com/Longroaderstar/status/1901464819125166144) 2025-03-17T02:45Z [---] followers, [----] engagements "$sgmo In this game risk management is paramount. I can afford to lose 1x of my bet on Sangamo but cannot afford to miss 10x the gains when it becomes a neuro-powerhouse. $sgmo Having a Monday earnings release means they are putting final ink to a deal and wants to seal it. If terms dont work then prob a $20m to $30m financing to tide over till the big deals $200m land. Similar to a year ago. Take advantage of it. $sgmo Having a Monday earnings release means they are putting final ink to a deal and wants to seal it. If terms dont work then prob a $20m to $30m financing to tide over till the" [X Link](https://x.com/Longroaderstar/status/1901995206742077507) 2025-03-18T13:52Z [---] followers, [---] engagements "$prqr $lly About time to unveil. https://www.sitryx.com/news/sitryx-announces-partner-lilly-exercises-option-to-sit-011-for-chronic-autoimmune-and-inflammatory-diseases https://www.sitryx.com/news/sitryx-announces-partner-lilly-exercises-option-to-sit-011-for-chronic-autoimmune-and-inflammatory-diseases" [X Link](https://x.com/Longroaderstar/status/1902984470678081799) 2025-03-21T07:23Z [---] followers, [---] engagements "$xbi $ntla $edit $beam $crsp $verv $sln $arwr $wve $krro $prqr $sgmo $mgx $qure #xbi So GT stocks plunge due to RK FDA future. The science continues. The diseases are still there. Follow the smart money. Be contrarian" [X Link](https://x.com/Longroaderstar/status/1906884093654253686) 2025-04-01T01:39Z [---] followers, [----] engagements "$sgmo $lly Its now a [--] way race to Sangamo prized assets eventually - Genentech Astellas and now Lily. The delay could be due to buyout negotiations. Perfect fit for Prevail which is a Lily sub. $sgmo Enough bridge to a Fabry deal. Excellent Sandy delivered. https://t.co/PMuajmsI6W $sgmo Enough bridge to a Fabry deal. Excellent Sandy delivered. https://t.co/PMuajmsI6W" [X Link](https://x.com/Longroaderstar/status/1907974920560325107) 2025-04-04T01:54Z [---] followers, [---] engagements "$VIR Cash $1.1b 2Q catalyst - HBV [--] weeks off treatment data soon. HDV is a home run but only 10% of HBV market. Perhaps $1-2b" [X Link](https://x.com/Longroaderstar/status/1910004083433537969) 2025-04-09T16:17Z [---] followers, [---] engagements "$pfe $sgmo They do bad science and abandon good science. Worst company. Stock shows beyond covid lows to GFC lows. https://www.statnews.com/2025/04/14/pfizer-discontinue-danuglipron-glp-1-obesity-liver-toxicity/ https://www.statnews.com/2025/04/14/pfizer-discontinue-danuglipron-glp-1-obesity-liver-toxicity/" [X Link](https://x.com/Longroaderstar/status/1911753580132139060) 2025-04-14T12:09Z [---] followers, [---] engagements "@BiotechAnalysst $pfe Buying another obese company will seal its FATe. LOL" [X Link](https://x.com/Longroaderstar/status/1911935431056433400) 2025-04-15T00:11Z [---] followers, [--] engagements "$VIR Upcoming data EASL [----] from [--] to [--] May. Above 30% would be great" [X Link](https://x.com/Longroaderstar/status/1914331354202079690) 2025-04-21T14:52Z [---] followers, [---] engagements "$SLN Cash to [----]. $147m. Mkt cap $50m. Can zerlasiran find a suitor Its a big market for all but this is sold down so much. https://www.fiercebiotech.com/biotech/lilly-links-lepodisiran-durably-lower-lipoprotein-phase-2-providing-edge-over-amgen-and https://www.fiercebiotech.com/biotech/lilly-links-lepodisiran-durably-lower-lipoprotein-phase-2-providing-edge-over-amgen-and" [X Link](https://x.com/Longroaderstar/status/1915046373931782362) 2025-04-23T14:13Z [---] followers, [---] engagements "$SGMO Good volume and price today. Smelling a whiff of a deal next Monday" [X Link](https://x.com/Longroaderstar/status/1915406482729845168) 2025-04-24T14:04Z [---] followers, [---] engagements "$swtx #xbi $xbi This will unlock more flow in deals. Good sign. https://www.businesswire.com/news/home/20250427077657/en/Merck-KGaA-Darmstadt-Germany-to-Acquire-US-Biopharma-Company-SpringWorks-Therapeutics-to-Accelerate-Sustainable-Growth-of-Healthcare-Business https://www.businesswire.com/news/home/20250427077657/en/Merck-KGaA-Darmstadt-Germany-to-Acquire-US-Biopharma-Company-SpringWorks-Therapeutics-to-Accelerate-Sustainable-Growth-of-Healthcare-Business" [X Link](https://x.com/Longroaderstar/status/1916821786932756873) 2025-04-28T11:48Z [---] followers, [---] engagements "$prqr On track. "During the first quarter of [----] the Company achieved a milestone in the collaboration agreement with Eli Lilly earning $1.0 million." https://www.proqr.com/press-releases/proqr-announces-first-quarter-2025-operating-and-financial-resultsutm_source=Newsletter&utm_medium=email&utm_campaign=PR_emailalerts https://www.proqr.com/press-releases/proqr-announces-first-quarter-2025-operating-and-financial-resultsutm_source=Newsletter&utm_medium=email&utm_campaign=PR_emailalerts" [X Link](https://x.com/Longroaderstar/status/1920476083490861124) 2025-05-08T13:49Z [---] followers, [---] engagements "$sgmo Earnings call after market close today. Major US-China trade descalation. Coincidence Always watch mondays for a deal but this is special" [X Link](https://x.com/Longroaderstar/status/1921835648954081434) 2025-05-12T07:51Z [---] followers, [---] engagements "$arwr Solid quarter. Continues to deliver in clinic and BD. https://ir.arrowheadpharma.com/news-releases/news-release-details/arrowhead-pharmaceuticals-reports-fiscal-2025-second-quarter https://ir.arrowheadpharma.com/news-releases/news-release-details/arrowhead-pharmaceuticals-reports-fiscal-2025-second-quarter" [X Link](https://x.com/Longroaderstar/status/1922072484041331032) 2025-05-12T23:32Z [---] followers, [---] engagements "$SGMO Live another quarter to tell another story. Warrant price 75cts offering combined 50cts. Not Fabry deal yet as many expected but as always risk management is key in biotech. https://investor.sangamo.com/news-releases/news-release-details/sangamo-therapeutics-announces-pricing-230-million-underwritten https://investor.sangamo.com/news-releases/news-release-details/sangamo-therapeutics-announces-pricing-230-million-underwritten" [X Link](https://x.com/Longroaderstar/status/1922075568083812466) 2025-05-12T23:45Z [---] followers, [---] engagements "$ARWR Cheapest siRNA yet with multiple late stage p3 this year. If cards fall in place next $ALNY potential. https://news.abbvie.com/2025-05-14-AbbVie-and-ADARx-Pharmaceuticals-Announce-Collaboration-and-License-Option-Agreement-to-Develop-Next-Generation-siRNA-Therapies-Across-Multiple-Therapeutic-Areas https://news.abbvie.com/2025-05-14-AbbVie-and-ADARx-Pharmaceuticals-Announce-Collaboration-and-License-Option-Agreement-to-Develop-Next-Generation-siRNA-Therapies-Across-Multiple-Therapeutic-Areas" [X Link](https://x.com/Longroaderstar/status/1922976054517334359) 2025-05-15T11:23Z [---] followers, [----] engagements "$ntla $prme $edit $crsp $prqr $wve $krro $verve $beam #dna #rna $xbi #xbi Get ready for short squeezes. Hot Monday. Intellia announces positive two-year follow-up data from its ongoing Phase [--] study in #ATTR with polyneuropathy at the [----] @PNSociety1 Annual Meeting in Edinburgh (https://t.co/uHhguJ9OI2). HCPs: be sure to catch our oral and poster presentation and stop by our booth to meet our https://t.co/JDzKAsNzCf Intellia announces positive two-year follow-up data from its ongoing Phase [--] study in #ATTR with polyneuropathy at the [----] @PNSociety1 Annual Meeting in Edinburgh" [X Link](https://x.com/Longroaderstar/status/1924337085089235232) 2025-05-19T05:31Z [---] followers, [----] engagements "$SLN mRNAi Gold platform owns all IP of siRNA modification delivery construct etc. [--] patents. Phase [--] ready for CVD. Cash to [----]. Attractive target. Regulus and ADARx. $SLN Cash to [----]. $147m. Mkt cap $50m. Can zerlasiran find a suitor Its a big market for all but this is sold down so much. https://t.co/qDYXZV7rU9 $SLN Cash to [----]. $147m. Mkt cap $50m. Can zerlasiran find a suitor Its a big market for all but this is sold down so much. https://t.co/qDYXZV7rU9" [X Link](https://x.com/Longroaderstar/status/1924480363075948601) 2025-05-19T15:00Z [---] followers, [---] engagements "$CRSP $SLN Interesting. DNA editing to RNAi. Another siRNA deal. Matter of time. https://ir.crisprtx.com/news-releases/news-release-details/crispr-therapeutics-and-sirius-therapeutics-announce-multi https://ir.crisprtx.com/news-releases/news-release-details/crispr-therapeutics-and-sirius-therapeutics-announce-multi" [X Link](https://x.com/Longroaderstar/status/1924791884079366356) 2025-05-20T11:38Z [---] followers, [---] engagements "$SLN $ARWR Cannot contain my excitement. Another RNAi gets scooped up. https://www.globenewswire.com/news-release/2025/05/27/3088497/0/en/Biogen-and-City-Therapeutics-Announce-Strategic-Research-Collaboration-to-Develop-Select-Novel-RNAi-based-Therapies.html https://www.globenewswire.com/news-release/2025/05/27/3088497/0/en/Biogen-and-City-Therapeutics-Announce-Strategic-Research-Collaboration-to-Develop-Select-Novel-RNAi-based-Therapies.html" [X Link](https://x.com/Longroaderstar/status/1928293225518788608) 2025-05-30T03:31Z [---] followers, [---] engagements "#xbi $xbi Seems like deals are coming fast anf furious. https://www.globenewswire.com/news-release/2025/06/02/3091541/0/en/Press-Release-Sanofi-to-acquire-Blueprint-Medicines-expanding-portfolio-in-rare-immunological-disease-and-adding-early-stage-pipeline-in-immunology.html https://www.globenewswire.com/news-release/2025/06/02/3091541/0/en/Press-Release-Sanofi-to-acquire-Blueprint-Medicines-expanding-portfolio-in-rare-immunological-disease-and-adding-early-stage-pipeline-in-immunology.html" [X Link](https://x.com/Longroaderstar/status/1929409960779387184) 2025-06-02T05:29Z [---] followers, [---] engagements "@US_FDA @SecKennedy @DrMakaryFDA @DrOz @NIHDirector_Jay $SGMO Start with Hemophilia A and Fabry disease 👍. Sangamo is right at the doorstep with cures for both and is almost running out of money doing the right science. Give them a lifeline and tens of thousands will be cured. After this weeks cell and gene therapy roundtable at @US_FDA @SecKennedy joined @DrOzCMS @DrMakaryFDA and @NIHDirector_Jay to deliver a message directly to the American people about investing in cutting-edge cures. Cell and gene therapy holds promisebut it also demands https://t.co/sEC3tYZTxp After this weeks cell and" [X Link](https://x.com/Longroaderstar/status/1931633878818545877) 2025-06-08T08:46Z [---] followers, [----] engagements "@HHSGov @SecKennedy @US_FDA @DrOzCMS @DrMakaryFDA @NIHDirector_Jay Start with Hemophilia A and Fabry disease 👍. Sangamo $sgmo is right at the doorstep with cures for both and is almost running out of money doing the right science. Give them a lifeline and tens of thousands will be cured" [X Link](https://x.com/Longroaderstar/status/1931636162927702283) 2025-06-08T08:55Z [---] followers, [---] engagements "$verv Spending $1b is chum change for Lily. Too cheap. https://www.ft.com/content/53d021c9-d15f-4471-86ef-e9abfc3ae7db https://www.ft.com/content/53d021c9-d15f-4471-86ef-e9abfc3ae7db" [X Link](https://x.com/Longroaderstar/status/1934818374925898033) 2025-06-17T03:40Z [---] followers, [---] engagements "@pawcio2009 Morgan Stanley expects [--] rate cuts in [----]. Whole lot of us going bio heaven next year. LOL" [X Link](https://x.com/Longroaderstar/status/1938147567877165221) 2025-06-26T08:09Z [---] followers, [--] engagements "$xbi #xbi Morgan Stanley expects [--] rate cuts in [----]. And perhaps [--] this year. Nice setup to xbi 120" [X Link](https://x.com/Longroaderstar/status/1940426625663074715) 2025-07-02T15:05Z [---] followers, [---] engagements "$prme $ntla $beam $editas $crsp $mgx $sgmo $prqr $wve $krro With bio sentiment recovering and long weekend plus rate cuts bet on a DNA/RNA editing name being acquired next few weeks" [X Link](https://x.com/Longroaderstar/status/1940609134132711784) 2025-07-03T03:10Z [---] followers, [---] engagements "#xbi $xbi Don't sell your winners now that we are on the verge of a new bull in biotech. Many names will 10x some even 100x. SoftBank was the largest shareholder of Nvidia. but they sold their entire 4.9% stake in Nvidia in [----] for $3.6B. It's worth $200B today. Jensen Huang made fun of Masa in front of him is so funny lmao https://t.co/a6qeNbhDtR SoftBank was the largest shareholder of Nvidia. but they sold their entire 4.9% stake in Nvidia in [----] for $3.6B. It's worth $200B today. Jensen Huang made fun of Masa in front of him is so funny lmao https://t.co/a6qeNbhDtR" [X Link](https://x.com/Longroaderstar/status/1944771203845251107) 2025-07-14T14:49Z [---] followers, [---] engagements "$vtyx Very decent upside as it is below cash Mkt cap only $210m and compared to $VKTX $3.2b. Seriously should reject any Sanofi offer below $1b. $vtyx Market cap $180m below cash and with two large indications of Parkinsons and Obesity. Nice rebound off lows. Impt readout end of Q3. $vtyx Market cap $180m below cash and with two large indications of Parkinsons and Obesity. Nice rebound off lows. Impt readout end of Q3" [X Link](https://x.com/Longroaderstar/status/1945166118999728535) 2025-07-15T16:58Z [---] followers, [---] engagements "$vtyx Both Ventyx and Nodthera preclinical results show enhanced weight loss and other parameters with semaglutide. This represents a new approach to obesity treatment using NRLP3 inflammasome inhibitor. See if there is any pullback to add. $vktx mc is $3.6b here only $230m" [X Link](https://x.com/Longroaderstar/status/1946098849321554126) 2025-07-18T06:44Z [---] followers, [---] engagements "$mgx Market cap of only $80m with cash of over $200m. Platform looks really good. Pipeline just a tad earlier than $prme" [X Link](https://x.com/Longroaderstar/status/1948029332691259649) 2025-07-23T14:36Z [---] followers, [---] engagements "$mgx 1/5 the market cap of $prme but twice the cash. Hope they throw off Hem A and go big on cardio" [X Link](https://x.com/Longroaderstar/status/1949841720960819442) 2025-07-28T14:37Z [---] followers, [---] engagements "$prqr Also one month out to CTA submission for AX-0810 on [--] June. Expect approval soon" [X Link](https://x.com/Longroaderstar/status/1949848281049334071) 2025-07-28T15:03Z [---] followers, [---] engagements "$prme Better late than never responsible raise with some dilution. https://www.globenewswire.com/news-release/2025/07/31/3124616/0/en/Prime-Medicine-Announces-Pricing-of-Public-Offering.html https://www.globenewswire.com/news-release/2025/07/31/3124616/0/en/Prime-Medicine-Announces-Pricing-of-Public-Offering.html" [X Link](https://x.com/Longroaderstar/status/1950909952916336928) 2025-07-31T13:22Z [---] followers, [---] engagements "$arwr Becoming late stage commercial soon once approved.re-rating due. Today we announced the signing of an asset purchase agreement between Sanofi and Visirna a subsidiary of Arrowhead to develop and commercialize investigational plozasiran in Greater China Learn more in our press release here: https://t.co/oOwVDRKfG3 https://t.co/uAdfcq17Kw Today we announced the signing of an asset purchase agreement between Sanofi and Visirna a subsidiary of Arrowhead to develop and commercialize investigational plozasiran in Greater China Learn more in our press release here: https://t.co/oOwVDRKfG3" [X Link](https://x.com/Longroaderstar/status/1951238610503565822) 2025-08-01T11:08Z [---] followers, [---] engagements "$prqr "Hosting fall Analyst and Investor Event (virtual) featuring detailed AX-0810 Phase [--] trial design and [----] data expectations plus updates across differentiated liver and CNS pipeline" https://www.proqr.com/press-releases/proqr-announces-second-quarter-2025-operating-and-financial-results https://www.proqr.com/press-releases/proqr-announces-second-quarter-2025-operating-and-financial-results" [X Link](https://x.com/Longroaderstar/status/1953435434740068708) 2025-08-07T12:37Z [---] followers, [----] engagements "$prqr Finally some data for [----] and CTA approval coming" [X Link](https://x.com/Longroaderstar/status/1953435841398727044) 2025-08-07T12:39Z [---] followers, [---] engagements "#xbi $xbi "President Trump has explicitly stated that his new Fed Chair pick must cut rates." Party time. Fed Chair Powell has caved: In [--] month the Fed will CUT rates and blame a "weaker labor market." Meanwhile we now have PPI inflation growth at a 3-year high and CPI inflation above 2% for 53-STRAIGHT months. Don't own assets You will be left behind. Here's why. (a thread) https://t.co/E1pFkDJbIQ Fed Chair Powell has caved: In [--] month the Fed will CUT rates and blame a "weaker labor market." Meanwhile we now have PPI inflation growth at a 3-year high and CPI inflation above 2% for" [X Link](https://x.com/Longroaderstar/status/1959551395318903002) 2025-08-24T09:40Z [---] followers, [---] engagements "$SRPT [--] Aug should be 5th trading day of convertible note pricing issuance close [--] Aug. Debt pushed back to [----] with some dilution. Still a good situation especially if non-ambulatory resumes. Been more than [--] months since suspension on [--] June" [X Link](https://x.com/Longroaderstar/status/1960491677233373344) 2025-08-26T23:56Z [---] followers, [---] engagements "$arwr $200m upfront for a preclinical. Market is not paying enough attention yet. https://ir.arrowheadpharma.com/news-releases/news-release-details/arrowhead-pharmaceuticals-and-novartis-enter-global-license-and https://ir.arrowheadpharma.com/news-releases/news-release-details/arrowhead-pharmaceuticals-and-novartis-enter-global-license-and" [X Link](https://x.com/Longroaderstar/status/1962873775202132446) 2025-09-02T13:42Z [---] followers, [---] engagements "@BiomedicalRX $arwr More than 10x difference in market cap $alny and 2.5x with $IONS. Surely potential for further upside early innings here. Adding" [X Link](https://x.com/Longroaderstar/status/1963192665224462357) 2025-09-03T10:49Z [---] followers, [---] engagements "$QURE "AMT-191 showed a manageable safety profile." Two SAEs out of [--] patients at higher dose. Second cohort with 1/3 dose seems much better. Still much farther behind than $sgmo with excellent safety and BLA early 2026" [X Link](https://x.com/Longroaderstar/status/1963961423135965554) 2025-09-05T13:44Z [---] followers, [---] engagements "$arwr Why are we are not at $5b already with such an excellent pipeline. https://ir.arrowheadpharma.com/news-releases/news-release-details/arrowhead-pharmaceuticals-requests-regulatory-clearance-0 https://ir.arrowheadpharma.com/news-releases/news-release-details/arrowhead-pharmaceuticals-requests-regulatory-clearance-0" [X Link](https://x.com/Longroaderstar/status/1965778085699350974) 2025-09-10T14:03Z [---] followers, [---] engagements "$sgmo $arvn $pfe At least Sangamo owns the whole HemA drug. This is like a jilted lover refusing to leave. Another dump by Pfizer. https://ir.arvinas.com/news-releases/news-release-details/arvinas-provides-update-collaboration-pfizer-and-announces/ https://ir.arvinas.com/news-releases/news-release-details/arvinas-provides-update-collaboration-pfizer-and-announces/" [X Link](https://x.com/Longroaderstar/status/1968603922404151796) 2025-09-18T09:12Z [---] followers, [---] engagements "$arvn $pfe $sgmo Called it. Pfizer is the worst partner. They dump both good and bad drugs. $arvn $pfe $sgmo Looks like Pfizer may jilt this one too https://t.co/9SkPTrC9ns $arvn $pfe $sgmo Looks like Pfizer may jilt this one too https://t.co/9SkPTrC9ns" [X Link](https://x.com/Longroaderstar/status/1968624914098721147) 2025-09-18T10:35Z [---] followers, [---] engagements "@commonsenseplay $srpt The pressure to release the hold in non-ambulatory builds" [X Link](https://x.com/Longroaderstar/status/1968846210652950682) 2025-09-19T01:14Z [---] followers, [---] engagements "$pfe $vktx Pfizer famously overpaid for Seagen. About to repeat the same mistake paying almost 3x mkt cap of Viking.only time will tell. https://finance.yahoo.com/news/pfizer-closes-7-3-billion-040417337.html https://finance.yahoo.com/news/pfizer-closes-7-3-billion-040417337.html" [X Link](https://x.com/Longroaderstar/status/1970078508597838139) 2025-09-22T10:51Z [---] followers, [---] engagements "$mgx $prme Similar cash levels around $200m one is a unicorn soon and the other languishing at 10% market cap only. Star scientist pull is really strong but I like the setup here" [X Link](https://x.com/Longroaderstar/status/1970857696137232560) 2025-09-24T14:27Z [---] followers, [---] engagements "$vtyx 1/3 Nice close above $3 to begin Q4. Ventyx should be the furthest in the field of NRLP3 human trials imminent data early Oct" [X Link](https://x.com/Longroaderstar/status/1972829680731566125) 2025-09-30T01:03Z [---] followers, [---] engagements "2/3 NLRP3 contains a PRYIN domain (PYD) a nucleotide binding and oligomerization domain (NACHT) an N-terminal caspase activation and recruitment domain (CARD) and a C-terminal leucine-rich repeats (LRRs)" [X Link](https://x.com/Longroaderstar/status/1972831388186653084) 2025-09-30T01:10Z [---] followers, [---] engagements "$xbi #xbi Xbi should gain strength towards end of the year. Interest rates got to go way down. It is a tailwind. ADP REPORT: NUMBER OF JOBS CREATED IN AUGUST WAS REVISED TO [-----] FROM [-----] ADP REPORT: NUMBER OF JOBS CREATED IN AUGUST WAS REVISED TO [-----] FROM 54000" [X Link](https://x.com/Longroaderstar/status/1973372932643819698) 2025-10-01T13:02Z [---] followers, [---] engagements "$pali 70cts Not even giving a decent premium for price discovery. Stockholders massive dilution. https://www.globenewswire.com/news-release/2025/10/02/3160698/0/en/Palisade-Bio-Announces-Closing-of-Upsized-138-Million-Public-Offering-of-Common-Stock-and-Including-Full-Exercise-of-Over-Allotment-Option.html https://www.globenewswire.com/news-release/2025/10/02/3160698/0/en/Palisade-Bio-Announces-Closing-of-Upsized-138-Million-Public-Offering-of-Common-Stock-and-Including-Full-Exercise-of-Over-Allotment-Option.html" [X Link](https://x.com/Longroaderstar/status/1974033946481434896) 2025-10-03T08:49Z [---] followers, [---] engagements "@RNAiAnalyst $mgx Just need a spark to ignite FOMO here" [X Link](https://x.com/Longroaderstar/status/1975386676752212367) 2025-10-07T02:24Z [---] followers, [---] engagements "$srpt Seems the younger they are the better chances of reversing this deadly disease. $SRPT WMS [----] a) no Treatment related SAEs in 3-4 years old (ambulatory).no new safety signals b) micro-dystrophin expression is higher in 3-4 years old compare to =5 years of age https://t.co/bninAqJW6S $SRPT WMS [----] a) no Treatment related SAEs in 3-4 years old (ambulatory).no new safety signals b) micro-dystrophin expression is higher in 3-4 years old compare to =5 years of age https://t.co/bninAqJW6S" [X Link](https://x.com/Longroaderstar/status/1975790132155588875) 2025-10-08T05:07Z [---] followers, [----] engagements "$vtyx Reminder Sanofi acquired Vigil for $470m + $100m CVR single Alzheimer's. Parkinson's Cardiometabolic and Recurrent Pericarditis should go for no less than $1b. A great quarter to drop good data" [X Link](https://x.com/Longroaderstar/status/1975816271976694091) 2025-10-08T06:51Z [---] followers, [---] engagements "$xbi #xbi The deals keep coming every week.healthy sign of more to come https://www.wsj.com/health/pharma/johnson-johnson-in-talks-to-buy-protagonist-therapeutics-38e0b69d https://www.wsj.com/health/pharma/johnson-johnson-in-talks-to-buy-protagonist-therapeutics-38e0b69d" [X Link](https://x.com/Longroaderstar/status/1976905943112991138) 2025-10-11T07:01Z [---] followers, [--] engagements "@Soeren_Berlin @ZinselmeyerB $sgmo Mostly milestone money. The real moolah is not spent yet" [X Link](https://x.com/Longroaderstar/status/1978267458080256416) 2025-10-15T01:11Z [---] followers, [---] engagements "$xbi #xbi $omer And yet another rare disease. https://www.globenewswire.com/news-release/2025/10/15/3167091/0/en/Novo-Nordisk-and-Omeros-announce-asset-purchase-and-license-agreement-for-Omeros-clinical-stage-MASP-3-inhibitor-zaltenibart-OMS906.html https://www.globenewswire.com/news-release/2025/10/15/3167091/0/en/Novo-Nordisk-and-Omeros-announce-asset-purchase-and-license-agreement-for-Omeros-clinical-stage-MASP-3-inhibitor-zaltenibart-OMS906.html" [X Link](https://x.com/Longroaderstar/status/1978453882813493628) 2025-10-15T13:32Z [---] followers, [---] engagements "@yaireinhorn @igisci @RNAiAnalyst $MGX Metagenomi should reverse course and cut HemA trial. Tackle the bigger indications like Alzheimers'. Jill Banfield was co-founder of Metagenomi. Now Brian the other founder is out and it is LOST" [X Link](https://x.com/Longroaderstar/status/1991774843612848495) 2025-11-21T07:45Z [---] followers, [---] engagements "$kron Calling Tang and others attractive dismantle works here. Cash $160m est" [X Link](https://x.com/Longroaderstar/status/1763751552748286311) 2024-03-02T02:21Z [---] followers, [---] engagements "$KRON Extend cash to 2H [----] lots data coming add on dips here" [X Link](https://x.com/Longroaderstar/status/1766105055361458322) 2024-03-08T14:13Z [---] followers, [---] engagements "$SGMO 2/2 If there is no deal why did the Board not undertake strategic review and 50% or 75% layoffs in Q1 like what $GLTO $AVRO and many others have done. Lean down and solicit asset/IP sales. Patience but risk adjust please. Only invest what you can lose completely. $SGMO 1/2 It takes time to conclude deals.at least [--] months to as long as a year or more. Likely shorts will pull this down below 50s again.patience is the most difficult thing. $SGMO 1/2 It takes time to conclude deals.at least [--] months to as long as a year or more. Likely shorts will pull this down below 50s again.patience is" [X Link](https://x.com/Longroaderstar/status/1801843413228392828) 2024-06-15T05:05Z [---] followers, [----] engagements "$ACHL $95m cash last mkt cap $29m. Finally. https://ir.achillestx.com/news-releases/news-release-details/achilles-therapeutics-announces-strategic-update https://ir.achillestx.com/news-releases/news-release-details/achilles-therapeutics-announces-strategic-update" [X Link](https://x.com/Longroaderstar/status/1836745010886451643) 2024-09-19T12:31Z [---] followers, [--] engagements "$wve $prqr $krro Fantastic news https://ir.wavelifesciences.com/news-releases/news-release-details/wave-life-sciences-announces-first-ever-therapeutic-rna-editing https://ir.wavelifesciences.com/news-releases/news-release-details/wave-life-sciences-announces-first-ever-therapeutic-rna-editing" [X Link](https://x.com/Longroaderstar/status/1846545835980648671) 2024-10-16T13:36Z [---] followers, [---] engagements "$cdmo $xbi The M&A spigot is on. https://ir.avidbio.com/news-releases/news-release-details/avid-bioservices-be-acquired-gho-capital-partners-and-ampersand https://ir.avidbio.com/news-releases/news-release-details/avid-bioservices-be-acquired-gho-capital-partners-and-ampersand" [X Link](https://x.com/Longroaderstar/status/1854393385945383134) 2024-11-07T05:20Z [---] followers, [----] engagements "$arwr Unbelievable this is still stuck at $22 after the BD with $SRPT clinical updates and all. What can save this sector Just buyout. Only farts and shitcoins matter" [X Link](https://x.com/Longroaderstar/status/1867588673136652354) 2024-12-13T15:13Z [---] followers, [---] engagements "@ZinselmeyerB @Gr8unionsJohn @adamfeuerstein @SangamoTx $SGMO HCW - short term financing is always an option. Believe Fabry deal is close past [--] months now. $ADVM the other presentee juiced up $127.5m 20% premium [--] year ago. https://investors.adverum.com/press_releases/news-details/2024/Adverum-Biotechnologies-Announces-127.5-Million-Private-Placement-Financing/default.aspx https://investors.adverum.com/press_releases/news-details/2024/Adverum-Biotechnologies-Announces-127.5-Million-Private-Placement-Financing/default.aspx" [X Link](https://x.com/Longroaderstar/status/1878985283448054088) 2025-01-14T01:59Z [---] followers, [----] engagements "$TECX $AVRO Previously Avrobio. Thats why reverse mergers are sometimes great https://investors.tectonictx.com/news-releases/news-release-details/tectonic-therapeutic-announces-positive-interim-data-phase-1b https://investors.tectonictx.com/news-releases/news-release-details/tectonic-therapeutic-announces-positive-interim-data-phase-1b" [X Link](https://x.com/Longroaderstar/status/1885157500556894554) 2025-01-31T02:45Z [---] followers, [---] engagements "@BiotechAnalysst @mchilberg Astellas zeroing fast on $sgmo who would'nt Two BLA ready drugs this year STAC-BBB MINT is the future. Its maybe a bidding war with Roche. Poseida redux" [X Link](https://x.com/Longroaderstar/status/1890070591686033511) 2025-02-13T16:08Z [--] followers, [---] engagements "$VTYX Forget Crohn main event is Parkinsons in H1 [----] and NLRP3 for obesity in H2 [----]. Market cap $117m cash $253m. https://ir.ventyxbio.com/news-releases/news-release-details/ventyx-biosciences-highlights-2025-pipeline-strategy-and https://ir.ventyxbio.com/news-releases/news-release-details/ventyx-biosciences-highlights-2025-pipeline-strategy-and" [X Link](https://x.com/Longroaderstar/status/1892231786387685578) 2025-02-19T15:16Z [--] followers, [---] engagements Limited data mode. Full metrics available with subscription: lunarcrush.com/pricing
@Longroaderstar Longroader
Longroader posts on X about $arwr, $prqr, $sgmo, $vtyx the most. They currently have [---------] followers and [---] posts still getting attention that total [-------] engagements in the last [--] hours.
Engagements: [-------] #
- [--] Week [-----] -7.30%
- [--] Month [-----] -57%
- [--] Months [-------] +196%
- [--] Year [-------] +81%
Mentions: [--] #
- [--] Month [--] -69%
- [--] Months [---] +198%
- [--] Year [---] +79%
Followers: [---------] #
- [--] Week [---] +0.45%
- [--] Month [---] +3.70%
- [--] Months [---] +58%
- [--] Year [---] +127%
CreatorRank: [---------] #
Social Influence
Social category influence stocks finance countries cryptocurrencies technology brands us election travel destinations exchanges celebrities social networks
Social topic influence $arwr, $prqr #1, $sgmo, $vtyx, $xbi, $lly, $pfe, $wve, $mgx, sanofi
Top accounts mentioned or mentioned by @rnaianalyst @biotechanalysst @proqr @mchilberg @drmakaryfda @bioboyscout @usfda @zinselmeyerb @seedy19tron @bioman944918473 @francaole @seckennedy @nihdirectorjay @drozcms @pawcio2009 @yaireinhorn @igisci @mattyjc @tuckerblows @smarting1121
Top assets mentioned Arrowhead Research Corporation (ARWR) Ventyx Biosciences, Inc. (VTYX) Eli Lilly and Company (LLY) Pfizer, Inc. (PFE) Wave Life Sciences Ltd. Ordinary Shares (WVE) Metagenomi Technologies, LLC (MGX) Sanofi (SNY) Iovance Biotherapeutics, Inc. Common Stock (IOVA) Sarepta Therapeutics, Inc. (SRPT) Vir Biotechnology, Inc. Common Stock (VIR) Prime Medicine, Inc. (PRME) Viking Therapeutics, Inc (VKTX) Ionis Pharmaceuticals, Inc. Common Stock (IONS) CRISPR Therapeutics AG (CRSP) Intellia Therapeutics, Inc (NTLA) Alnylam Pharmaceuticals, Inc. (ALNY) Abivax SA (ABVX) Novo-Nordisk (NVO) BEAM (BEAM) GSK plc (GSK) Smart Layer Network (SLN) Tourmaline Bio, Inc. (TRML) Cidara Therapeutics, Inc. (CDTX) Novartis AG (NVS) Synthetify (SNY) uniQure N.V. (QURE) NVIDIA Corp. (NVDA) Moderna Inc (MRNA) Kronos Bio, Inc. (KRON) Poseida Therapeutics, Inc. (PSTX) Arvinas, Inc (ARVN) BioAge Labs, Inc. (BIOA) Avidity Biosciences, Inc. (RNA) Freeline Therapeutics Holdings plc (FRLN) Amicus Therapeutics, Inc (FOLD) Johnson & Johnson (JNJ)
Top Social Posts
Top posts by engagements in the last [--] hours
"@RNAiAnalyst $tpst Chapter [--] obviously doesnt bother them"
X Link 2023-10-13T01:40Z [--] followers, [--] engagements
"$AVRO $FRLN Gaucher cousins approx cash level buyout. So cheap now"
X Link 2023-10-19T06:22Z [--] followers, [---] engagements
"$LLY Small and early stage $PRQR"
X Link 2024-01-10T01:53Z [--] followers, [---] engagements
"$PRQR Van Herk picked up 5.3% in Sept [----]. Strong buying last [--] weeks. $LLY feeling the squeeze"
X Link 2024-01-17T14:46Z [--] followers, [---] engagements
"$prqr $lly Similar structure deal entering Phase [--] ProQR-Lily deal update next"
X Link 2024-01-23T09:22Z [--] followers, [---] engagements
"$prqr Current mcap $165m $WVE $499m $KRRO $405m Expect this gap to narrow as clinicals trials initiate later this year"
X Link 2024-02-23T13:48Z [--] followers, [---] engagements
"$SGMO 1/4 Potential of fabry disease market Estimates range from [-----] to [-----] individuals with fabry gene in the US alone"
X Link 2024-03-04T09:58Z [--] followers, [----] engagements
"2/4 Leading treatment is Fabrazyme an enzyme replacement therapy from Sanofi. Latest FY2023 sales figures at 991m ($1.25b) increasing patient accurals"
X Link 2024-03-04T10:02Z [---] followers, [---] engagements
"3/4 Novel treatment Galafold from Amicus Therapeutics an oral option for adults with confirmed Fabry disease and anamenableGLAgenevariant. Full year sales FY23 was $387m projecting strong FY24 growth between 11% to 16%"
X Link 2024-03-04T10:09Z [---] followers, [---] engagements
"$sgmo $biib $nvs $vygr Reshuffle the cards. Pick the better capsid. STAC-BBB https://ir.voyagertherapeutics.com/news-releases/news-release-details/voyager-therapeutics-enters-capsid-license-agreement-and https://ir.voyagertherapeutics.com/news-releases/news-release-details/voyager-therapeutics-enters-capsid-license-agreement-and"
X Link 2024-03-15T00:16Z [--] followers, [----] engagements
"$SWAV $JNJ #xbi Money coming off sidelines. https://www.businesswire.com/news/home/20240405052557/en/ https://www.businesswire.com/news/home/20240405052557/en/"
X Link 2024-04-05T11:18Z [--] followers, [--] engagements
"$prqr All eyes on $LLY post strawmen challenges. Can easily go to $5 if $LLY exercises its options. Sitryx is a good case study. https://www.sitryx.com/news/sitryx-announces-partner-lilly-exercises-option-to-sit-011-for-chronic-autoimmune-and-inflammatory-diseases https://www.sitryx.com/news/sitryx-announces-partner-lilly-exercises-option-to-sit-011-for-chronic-autoimmune-and-inflammatory-diseases"
X Link 2024-04-22T14:16Z [--] followers, [---] engagements
"@BioMan944918473 @RNAiAnalyst $PRQR $LLY [--] years of silence finally [--] poster. This AGM shareholders must push for more data"
X Link 2024-04-23T14:17Z [--] followers, [---] engagements
"$ARWR Busy month with [--] late breakers https://ir.arrowheadpharma.com/news-releases/news-release-details/arrowhead-pharmaceuticals-participate-upcoming-may-2024 https://ir.arrowheadpharma.com/news-releases/news-release-details/arrowhead-pharmaceuticals-participate-upcoming-may-2024"
X Link 2024-04-29T14:21Z [--] followers, [---] engagements
"#inflation #xbi $SBUX $MCD Staples of American consumer BREAKING: Starbucks stock $SBUX extends its decline to -16% today hitting its lowest level since June [----]. The stock has now erased $35 BILLION in market cap since it hit its all time high in [----]. Globally Starbucks saw 6% decline in customer traffic in Q1 [----] ALONE. The https://t.co/4LPXy5FNQW BREAKING: Starbucks stock $SBUX extends its decline to -16% today hitting its lowest level since June [----]. The stock has now erased $35 BILLION in market cap since it hit its all time high in [----]. Globally Starbucks saw 6% decline in customer"
X Link 2024-05-01T14:53Z [--] followers, [---] engagements
"$prqr $lly .potential additional milestone income from existing partnership and potential option to exercise for expansion of deal to [--] targets. https://www.proqr.com/press-releases/proqr-announces-first-quarter-2024-operating-and-financial-results https://www.proqr.com/press-releases/proqr-announces-first-quarter-2024-operating-and-financial-results"
X Link 2024-05-09T12:07Z [--] followers, [---] engagements
"$otly $pton Oatly similar play to peloton. Private equity maybe a better option"
X Link 2024-05-09T14:50Z [--] followers, [---] engagements
"$NVDA Trading like insatiable demand for AI chips last forever. Tulips. Credit"
X Link 2024-05-29T14:56Z [--] followers, [--] engagements
"$arct $1.1b $mrna $57b $bntx $24.5b Cheapest $cvac $0.97b"
X Link 2024-06-03T15:25Z [--] followers, [---] engagements
"$LLY $NVO $VKTX Still think weight loss drugs are the answer 🚨10000 LAWSUITS HIT OZEMPIC WEGOVY AND MOUNJARO OVER SEVERE SIDE EFFECTS Ozempic and similar shots like Wegovy and Mounjaro are reportedly facing up to [-----] lawsuits from patients who claim the drugs caused debilitating side effects like stomach paralysis and 'tearing https://t.co/euJ0dI0686 🚨10000 LAWSUITS HIT OZEMPIC WEGOVY AND MOUNJARO OVER SEVERE SIDE EFFECTS Ozempic and similar shots like Wegovy and Mounjaro are reportedly facing up to [-----] lawsuits from patients who claim the drugs caused debilitating side effects like"
X Link 2024-06-13T09:18Z [--] followers, [---] engagements
"$cvac $bntx $mrna $pfe Get ready https://youtu.be/QGsM9IgVAJofeature=shared https://youtu.be/QGsM9IgVAJofeature=shared"
X Link 2024-06-16T14:52Z [--] followers, [---] engagements
"@mattyjc @TuckerBlows @BiotechAnalysst $SGMO $PFE Or rather than pay $250m milestone offer that to buy over the whole company. Its a good bargain"
X Link 2024-06-18T13:48Z [--] followers, [---] engagements
"#Bigtech #xbi When bigtech loses trillionaire status biotech will shine Market cap of Nvidia alone today is the entire size of Nasdaq during dotcom. A matter of time. Patience"
X Link 2024-06-19T00:23Z [--] followers, [--] engagements
"Short $NVDA and other Mag7 Long #Xbi $xbi Looks like a good trade heading into bubble deflation"
X Link 2024-06-24T14:41Z [--] followers, [---] engagements
"$PRQR $LLY better decide fast or watch Dicerna [---] @smarting1121 Roche has a huntingtin-repeat CAG-targeting RNAediting patent app with promising data. Maybe they'll buy $PRQR :). @smarting1121 Roche has a huntingtin-repeat CAG-targeting RNAediting patent app with promising data. Maybe they'll buy $PRQR :)"
X Link 2024-06-26T14:15Z [--] followers, [---] engagements
"$lly $morf Ok ATH is the asking now. https://www.prnewswire.com/news-releases/lilly-to-acquire-morphic-to-improve-outcomes-for-patients-with-inflammatory-bowel-disease-302190489.html https://www.prnewswire.com/news-releases/lilly-to-acquire-morphic-to-improve-outcomes-for-patients-with-inflammatory-bowel-disease-302190489.html"
X Link 2024-07-08T11:02Z [--] followers, [--] engagements
"$pfe $vktx Not buying $vktx or maybe a negotiation tactic https://www.businesswire.com/news/home/20240710971928/en/ https://www.businesswire.com/news/home/20240710971928/en/"
X Link 2024-07-11T11:25Z [--] followers, [---] engagements
"$SGMO Last [--] days either [--]. Shorts who have positioned for the big B probably covering or [--]. Deal/buyout/HemA readout is on the table. Likely both"
X Link 2024-07-11T13:46Z [--] followers, [---] engagements
"$prqr $mreo $arwr $adap $kron $achl $sgmo $cvac #xbi $xbi [---] Time for the microbots to steal the show Please do your own due diligence. Not investment advice"
X Link 2024-07-16T13:48Z [--] followers, [----] engagements
"$xbi #xbi IMO whether its Trump or Harris or anyone esle its gonna be one way ticket for the greatest bull XBI. Period. 150"
X Link 2024-07-22T13:39Z [--] followers, [---] engagements
"$SGMO $PFE Down to the wire [--] July. Its Pfizer's to call. $SGMO clock is clicking louder now that they are in 3Q. Recap of prior funding status statements https://t.co/bdyoX90uPa $SGMO clock is clicking louder now that they are in 3Q. Recap of prior funding status statements https://t.co/bdyoX90uPa"
X Link 2024-07-23T08:41Z [--] followers, [----] engagements
"$pfe $sgmo We look forward to advancing this latest innovation to help address the medical and treatment burden associated with frequent and time-consuming IV infusions or injections building on Pfizers more than 40-year effort to advance hemophilia treatment"
X Link 2024-07-24T13:56Z [--] followers, [---] engagements
"$adap No reason to sell patience. Fantastic platform attractive buyout candidate"
X Link 2024-08-02T14:47Z [--] followers, [---] engagements
"$prqr Gearing up to sig data release in next [--] months and milestone payment right on track from $LLY. https://www.proqr.com/press-releases/proqr-announces-second-quarter-2024-operating-and-financial-results https://www.proqr.com/press-releases/proqr-announces-second-quarter-2024-operating-and-financial-results"
X Link 2024-08-08T14:54Z [--] followers, [---] engagements
"$prqr Preclinical is hitting $1b for promising assets. Patience here for a nice buyout. https://www.biospace.com/novartis-buys-mariana-oncology-in-1b-acquisition-bolsters-radiopharma-assets https://www.biospace.com/novartis-buys-mariana-oncology-in-1b-acquisition-bolsters-radiopharma-assets"
X Link 2024-08-15T00:09Z [--] followers, [---] engagements
"@BiotechAnalysst $SGMO LOL if it shoots 20x someone should get fired"
X Link 2024-08-17T10:50Z [--] followers, [---] engagements
"$MREO Great run up waiting for partnership news. Matter of time"
X Link 2024-08-19T16:12Z [--] followers, [---] engagements
"$abus Will $mrna still have the funds to pay potential liabilities due to LNP patent lawsuits https://finance.yahoo.com/news/moderna-slashes-research-budget-vaccine-102233791.html https://finance.yahoo.com/news/moderna-slashes-research-budget-vaccine-102233791.html"
X Link 2024-09-12T14:44Z [--] followers, [---] engagements
"$pfe The decision is based on the totality of clinical data which now indicates that the benefit of Oxbryta no longer outweighs the risks associated with its use Pfizer said."fatal events" which require further assessment. https://www.reuters.com/business/healthcare-pharmaceuticals/pfizer-withdraws-sickle-cell-disease-treatment-all-markets-2024-09-25/taid=66f480efb3d88c00011e6185&utm_campaign=trueanthem&utm_medium=trueanthem&utm_source=twitter"
X Link 2024-09-25T23:33Z [--] followers, [---] engagements
"$sgmo $pfe No surprise if Pfizer or another BP comes here. $SGMO says [--] patients data on new manufacturing drug in #sickle #cell looks as good as rest out the ie $CRSP = all 45%+ looking to partner $SGMO says [--] patients data on new manufacturing drug in #sickle #cell looks as good as rest out the ie $CRSP = all 45%+ looking to partner"
X Link 2024-09-26T06:07Z [--] followers, [---] engagements
"$sgmo What a mess Zinc Fingers. Patently clear. https://www.technologyreview.com/2024/09/25/1104475/nobel-prize-winners-cancel-crispr-patents-europe/ https://www.technologyreview.com/2024/09/25/1104475/nobel-prize-winners-cancel-crispr-patents-europe/"
X Link 2024-09-26T09:15Z [--] followers, [---] engagements
"#xbi $xbi Fed rate cuts + soft landing = boom time biotech"
X Link 2024-10-05T00:07Z [--] followers, [--] engagements
"$pfe $sgmo Triple combo"
X Link 2024-10-15T04:59Z [--] followers, [---] engagements
"@RNAiAnalyst @BioMan944918473 My healthy worry is they get bought out early at $3b in [----]. Its worth $30b for next few years. Not far fetch considering how hot the gene editing craze was in [----] and with lower interest rates. $prqr"
X Link 2024-10-20T10:18Z [---] followers, [---] engagements
"$PRQR $WVE $KRRO #RNA #RNAediting 1/8 With latest proof of mechanism (POM) of RNA editing in AATD human patients by $WVE here's why this field is going to dominate next year's biotech boom and why ProQR is the next big tech in this field"
X Link 2024-10-22T10:00Z [--] followers, [---] engagements
"2/8 Interest in RNA editing is only going to accelerate next year. Big pharma with the likes of Eli Lily GSK Novo Nordisk and Roche have already invested billions. More to come. See excellent article by Gerald Platenburg (ProQr). https://www.biospace.com/interest-in-rna-editing-accelerates-as-therapies-approach-the-clinic https://www.biospace.com/interest-in-rna-editing-accelerates-as-therapies-approach-the-clinic"
X Link 2024-10-22T10:00Z [--] followers, [---] engagements
"7/8 ProQR has the smallest market cap of $330m compared to Korro ($705m) and Wave ($2.2b) despite having pioneered the RNA editing field owns key patents differentiated pipeline and a giant partner (Eli Lily)"
X Link 2024-10-22T10:00Z [--] followers, [---] engagements
"8/8 Key catalysts for ProQR: preclinical data for IND in 4Q especially AX-1412 additional $50m by Lily for [--] more targets unveil on Lily targets new partnerships relatively quick trial results with healthy volunteers for POM (dyodd not investment advice)"
X Link 2024-10-22T10:00Z [--] followers, [---] engagements
"$SGMO Ridiculous this is still at tiny mkt cap of $300m and below $5 HemA P3 readout supports BLA milestone payment $220m incoming and royalties $1.9b deal with Genetech Fabry accelerated approval BLA [----] billion dollar market STAC-BBB prion MINT etc"
X Link 2024-10-22T14:42Z [---] followers, [----] engagements
"$prqr This should be priced above $3.5 possibly $50m with option 15% more. Funds seeking to enter. Next pl switch to Nasdaq direct listing. https://www.proqr.com/press-releases/proqr-announces-proposed-underwritten-public-offering-of-ordinary-shares https://www.proqr.com/press-releases/proqr-announces-proposed-underwritten-public-offering-of-ordinary-shares"
X Link 2024-10-23T00:55Z [---] followers, [---] engagements
"@RNAiAnalyst $prqr Demand is strong like recent Wave offering at $8 which now close to doubled. No surprise here"
X Link 2024-10-23T06:27Z [--] followers, [---] engagements
"#xbi $xbi $sgmo $prqr $mreo $arwr $vtyx $kron and others I dont discuss politics but if Trump wins in less than [--] weeks it is going to be incredibly bullish for biotech stocks Drill baby drill (oil) Cut baby cut (rates)"
X Link 2024-10-25T15:07Z [--] followers, [----] engagements
"$PRQR Nice end to the week cashed-up at $3.50 with $LLY as great partner. Feels like next few months entering clinic is going to be very significant here for the leader of this field. @ProQR #RNAediting 8/8 Key catalysts for ProQR: preclinical data for IND in 4Q especially AX-1412 additional $50m by Lily for [--] more targets unveil on Lily targets new partnerships relatively quick trial results with healthy volunteers for POM (dyodd not investment advice) 8/8 Key catalysts for ProQR: preclinical data for IND in 4Q especially AX-1412 additional $50m by Lily for [--] more targets unveil on Lily"
X Link 2024-10-26T07:54Z [---] followers, [----] engagements
"$SGMO Maintaining full position zero traded. Positive signs: No offering despite increase in stock price 167% ytd. Options market suggest huge movement soon Two late stage drugs (hemA/Fabry) maybe target of buyout Extremely undervalued at $311m mkt cap. $SGMO Ridiculous this is still at tiny mkt cap of $300m and below $5 HemA P3 readout supports BLA milestone payment $220m incoming and royalties $1.9b deal with Genetech Fabry accelerated approval BLA [----] billion dollar market STAC-BBB prion MINT etc $SGMO Ridiculous this is still at tiny mkt cap of $300m and below $5 HemA P3 readout supports"
X Link 2024-10-26T08:06Z [---] followers, [----] engagements
"@BiotechAnalysst $sgmo A generational investment opportunity only happens a few times in your lifetime. REGENERON NVIDA NETFLIX MONSTER BEVERAGE.100X baggers This COULD be one of them"
X Link 2024-10-28T10:51Z [---] followers, [---] engagements
"$sgmo Looks like STAC-BBB is worth a lot more now. https://www.prnewswire.com/news-releases/abbvie-to-acquire-aliada-therapeutics-strengthening-focus-in-alzheimers-disease-and-neuroscience-pipeline-302288180.html https://www.prnewswire.com/news-releases/abbvie-to-acquire-aliada-therapeutics-strengthening-focus-in-alzheimers-disease-and-neuroscience-pipeline-302288180.html"
X Link 2024-10-28T15:56Z [---] followers, [----] engagements
"@mchilberg After Abbvie and Roche news chances are the next poker card dealt is the one Sandy and the board chose. Or Fabry. The market realises. $SGMO"
X Link 2024-10-29T09:12Z [---] followers, [---] engagements
"@RNAiAnalyst Agree. $Vir is best in class in knockdowns so far in the HBV/HDV space compared to GSK and ABUS. GILD may make a move once they see enough data"
X Link 2024-11-01T00:41Z [--] followers, [---] engagements
"#XBI $xbi Futures for the small cap benchmark Russell [----] also a projected Trump beneficiary jumped 5%. https://www.cnbc.com/2024/11/05/stock-market-today-live-updates.html https://www.cnbc.com/2024/11/05/stock-market-today-live-updates.html"
X Link 2024-11-06T08:51Z [--] followers, [--] engagements
"#xbi $xbi $sgmo $prqr $mreo $arwr $vtyx $kron and others Lets get to $xbi [---] #xbi $xbi $sgmo $prqr $mreo $arwr $vtyx $kron and others I dont discuss politics but if Trump wins in less than [--] weeks it is going to be incredibly bullish for biotech stocks Drill baby drill (oil) Cut baby cut (rates) #xbi $xbi $sgmo $prqr $mreo $arwr $vtyx $kron and others I dont discuss politics but if Trump wins in less than [--] weeks it is going to be incredibly bullish for biotech stocks Drill baby drill (oil) Cut baby cut (rates)"
X Link 2024-11-06T13:53Z [--] followers, [----] engagements
"$sgmo Better than owning shitcoins like dodge coin with $60b marketcap. Next deal will happen. Its a matter of the right price and partner. Watching for any pipe deal or ATM sale none will be the best signal a deal is close. Ask yourself: is this pipeline worth $158m That is the current market capitalization of $SGMO https://t.co/ppRj29AC7X Ask yourself: is this pipeline worth $158m That is the current market capitalization of $SGMO https://t.co/ppRj29AC7X"
X Link 2024-11-12T13:12Z [--] followers, [----] engagements
"$sgmo $pfe Pfizer just made $4.4b for 3Q. And they are set to dominate the market for Hem A ($sgmo P3) and Hem B (Beqvez FDA approved in 2024). Hem A is [--] times more prevalent than Hem B. Anyone who thinks Pfizer walks away is delusional. Its reputational suicide as well"
X Link 2024-11-13T15:07Z [--] followers, [----] engagements
"$sgmo Healthy pull back from some speculative rumor of a Fabry deal in 3Q. Patience. Add to that RFK nomination and $xbi down 3%. After all the rhetoric is gone we still need cures for rare diseases and brain diseases. The people want quick approvals"
X Link 2024-11-15T02:53Z [--] followers, [---] engagements
"@PirateWaffle $kron Had wished 80mg works this would had 2x or 3x. Now gotta settle for 1x. Not too bad either. Its Nobert's call"
X Link 2024-11-15T17:02Z [--] followers, [---] engagements
"$arwr Great milestone Today we announced the submission of a New Drug Application (NDA) to the @US_FDA for our investigational #RNAi medicine for treatment of familial chylomicronemia syndrome (#FCS). We plan to submit applications for approval in [----]. Learn more: https://t.co/ycDYFhDUPC $ARWR https://t.co/36Sa568KwN Today we announced the submission of a New Drug Application (NDA) to the @US_FDA for our investigational #RNAi medicine for treatment of familial chylomicronemia syndrome (#FCS). We plan to submit applications for approval in [----]. Learn more: https://t.co/ycDYFhDUPC $ARWR"
X Link 2024-11-19T04:02Z [--] followers, [---] engagements
"$VIR HDV Phase [--] in [----] HBV Functional cure readout in Q2 Negative EV : @Vir_Biotech presented data from programs for chronic hepatitis B and chronic hepatitis delta at #TLM24. $VIR Full video: https://t.co/bhfORL2FHG https://t.co/6HaTPvvkfV : @Vir_Biotech presented data from programs for chronic hepatitis B and chronic hepatitis delta at #TLM24. $VIR Full video: https://t.co/bhfORL2FHG https://t.co/6HaTPvvkfV"
X Link 2024-11-22T15:50Z [--] followers, [---] engagements
"$prqr $lly Will Eli Lily acquire ProQr Already own 16.4%. #xbi $xbi $pstx Wow keep it flowing. $1.5b. Roche has seen enough to acquire the whole outfit. Was a [----] partnership $110m upfront $6b aggregate deal. https://t.co/P9RXeXOCII #xbi $xbi $pstx Wow keep it flowing. $1.5b. Roche has seen enough to acquire the whole outfit. Was a [----] partnership $110m upfront $6b aggregate deal. https://t.co/P9RXeXOCII"
X Link 2024-11-26T08:12Z [--] followers, [----] engagements
"$sgmo $pfe Will Pfizer acquire Sangamo Or Genentech #xbi $xbi $pstx Wow keep it flowing. $1.5b. Roche has seen enough to acquire the whole outfit. Was a [----] partnership $110m upfront $6b aggregate deal. https://t.co/P9RXeXOCII #xbi $xbi $pstx Wow keep it flowing. $1.5b. Roche has seen enough to acquire the whole outfit. Was a [----] partnership $110m upfront $6b aggregate deal. https://t.co/P9RXeXOCII"
X Link 2024-11-26T08:14Z [--] followers, [---] engagements
"$arwr Another deal Cash $825m immediate. Wow. https://ir.arrowheadpharma.com/news-releases/news-release-details/arrowhead-pharmaceuticals-announces-global-license-and https://ir.arrowheadpharma.com/news-releases/news-release-details/arrowhead-pharmaceuticals-announces-global-license-and"
X Link 2024-11-26T12:54Z [--] followers, [---] engagements
"$VIR #hdv #hbv GILEAD or GSK may be eyeing this. Best in class HDV and HBV. Pharmasset was acquired by Gilead in P3 for $11b in [----]. $VIR HDV Phase [--] in [----] HBV Functional cure readout in Q2 Negative EV $VIR HDV Phase [--] in [----] HBV Functional cure readout in Q2 Negative EV"
X Link 2024-11-26T15:55Z [--] followers, [---] engagements
"@RNAiAnalyst $arwr Such an underwhelming response today. BP could snatch it away while its still cheap. $80 is possible"
X Link 2024-11-27T02:11Z [--] followers, [---] engagements
"$ARWR $SRPT equity at $27.25. Shorts holding it down to unwind yesterday. Good let it rip now. Its a buyout target. Cash till 2028"
X Link 2024-11-27T14:51Z [--] followers, [---] engagements
"$SGMO $PTCT $1b upfront. Wow. If Takeda doesnt match up here another partner will step up. https://ir.ptcbio.com/news-releases/news-release-details/ptc-therapeutics-enters-global-license-and-collaboration Suppression of #Huntingtons Disease Somatic Instability by Transcriptional Repression and Direct CAG Repeat Binding $SGMO "we believe that #epigenetic #editing techniques such as #ZFPs have great theoretical #advantages as therapies for HD " https://t.co/DcryANPRJg https://ir.ptcbio.com/news-releases/news-release-details/ptc-therapeutics-enters-global-license-and-collaboration Suppression of"
X Link 2024-12-02T12:25Z [--] followers, [----] engagements
"$arwr There it is Today we announced we have filed a request for regulatory clearance to initiate a Phase 1/2a Study of ARO-ALK7 our second #RNAi therapy being developed as a potential treatment for obesity. Read more in our press release: https://t.co/2eLfp7Z2Ey https://t.co/wif8sOS0zG Today we announced we have filed a request for regulatory clearance to initiate a Phase 1/2a Study of ARO-ALK7 our second #RNAi therapy being developed as a potential treatment for obesity. Read more in our press release: https://t.co/2eLfp7Z2Ey https://t.co/wif8sOS0zG"
X Link 2024-12-04T10:31Z [--] followers, [---] engagements
"$sgmo Nicely forming a cup and handle. $pfe ASH [--] Dec and BLA is close"
X Link 2024-12-05T14:45Z [--] followers, [---] engagements
"$sgmo 1/3 Anyone fixated on cash runway. Prob $70m tied to BLA filing. https://www.investing.com/news/stock-market-news/earnings-call-sangamo-therapeutics-extends-cash-runway-into-2025-93CH-3560133 https://www.investing.com/news/stock-market-news/earnings-call-sangamo-therapeutics-extends-cash-runway-into-2025-93CH-3560133"
X Link 2024-12-06T08:27Z [--] followers, [---] engagements
"$prqr $lly Time to peel the wool away from the market. @RNAiAnalyst $prqr [--] years here too. Expects news before they enter clinical Q4. https://t.co/QcooMxjM01 @RNAiAnalyst $prqr [--] years here too. Expects news before they enter clinical Q4. https://t.co/QcooMxjM01"
X Link 2024-12-06T15:45Z [--] followers, [---] engagements
"$VIR Tcell event a side show. HDV and HBV is the $10b main event. $VIR #hdv #hbv GILEAD or GSK may be eyeing this. Best in class HDV and HBV. Pharmasset was acquired by Gilead in P3 for $11b in [----]. $VIR #hdv #hbv GILEAD or GSK may be eyeing this. Best in class HDV and HBV. Pharmasset was acquired by Gilead in P3 for $11b in 2011"
X Link 2024-12-07T00:31Z [--] followers, [---] engagements
"$arwr ARO-ALK7 next https://ir.bioagelabs.com/news-releases/news-release-details/bioage-labs-announces-discontinuation-strides-phase-2-clinical https://ir.bioagelabs.com/news-releases/news-release-details/bioage-labs-announces-discontinuation-strides-phase-2-clinical"
X Link 2024-12-07T00:36Z [--] followers, [---] engagements
"#xbi $xbi #COVID19 Here we go again. WHO deploys a team of experts to Congo to help investigate mysterious disease https://t.co/vsWZAJ7TCa WHO deploys a team of experts to Congo to help investigate mysterious disease https://t.co/vsWZAJ7TCa"
X Link 2024-12-07T05:30Z [--] followers, [--] engagements
"@Biotech2050 $sgmo $pfe They will complete the hemophilia franchise without a doubt"
X Link 2024-12-09T04:03Z [--] followers, [----] engagements
"$sgmo $pfe Estimate BLA Jan25 around inauguration and PDUFA July25 with priority review. Best in class treatment. Were excited for @pfizer #ASH2024 oral presentation today showcasing data from Ph.3 AFFINE trial of giroctocogene fitelparvovec a gene therapy that we co-developed with and licensed to PFE for the treatment of adults w/moderately severe to severe Hem A. https://t.co/Zj9sdsDcg7 Were excited for @pfizer #ASH2024 oral presentation today showcasing data from Ph.3 AFFINE trial of giroctocogene fitelparvovec a gene therapy that we co-developed with and licensed to PFE for the treatment"
X Link 2024-12-09T23:14Z [--] followers, [----] engagements
"@RNAiAnalyst $sgmo $mgx Perhaps as 2nd gen HemA gene Tx but IND filing [----] and BLA maybe [----]. Means no other shots come close to giroctocogene fitelparvovec for at least the next [--] years"
X Link 2024-12-10T11:38Z [--] followers, [---] engagements
"@RNAiAnalyst @stonkgang Surprised $arwr not in Top [--]. Cheap and cashed up"
X Link 2024-12-10T14:02Z [--] followers, [---] engagements
"$rvph More than doubled since last entry price. Data drop anytime now"
X Link 2024-12-11T17:07Z [--] followers, [---] engagements
"$SGMO $PFE [--] Dec. Drop some Christmas nuggets here. https://investors.pfizer.com/Investors/News/news-details/2024/Pfizer-Invites-Public-to-View-and-Listen-to-Webcast-of-December-17-Conference-Call-with-Analysts-to-Provide-Full-Year-2025-Financial-Guidance/default.aspx https://investors.pfizer.com/Investors/News/news-details/2024/Pfizer-Invites-Public-to-View-and-Listen-to-Webcast-of-December-17-Conference-Call-with-Analysts-to-Provide-Full-Year-2025-Financial-Guidance/default.aspx"
X Link 2024-12-12T15:28Z [--] followers, [----] engagements
"$prqr Good investor meeting laying out next [--] years with multiple clinical readouts can sense strong hints of new partnerships. Expect the pipeline to grow into a multi-billion powerhouse next few years"
X Link 2024-12-12T15:39Z [--] followers, [----] engagements
"$rvph May close above $3 today. Mcap below $100m. If they can show good set of data its going parabolic"
X Link 2024-12-12T15:51Z [--] followers, [---] engagements
"$sgmo $pfe Will Pfizer fast track BLA submission for giroctocogene fitelparvovec before the new Administration takes over If so Dec is possible. $sgmo $pfe Estimate BLA Jan25 around inauguration and PDUFA July25 with priority review. Best in class treatment. $sgmo $pfe Estimate BLA Jan25 around inauguration and PDUFA July25 with priority review. Best in class treatment"
X Link 2024-12-13T15:24Z [--] followers, [---] engagements
"$prqr Another crazy $xbi selloff day gene editing stocks slammed.RNA too. LOL. Patience here"
X Link 2024-12-13T16:50Z [--] followers, [---] engagements
"#NASDAQ #bullrun #BearBull This probably tops the market. Super bearish. BREAKING: MicroStrategy $MSTR is joining the Nasdaq [---] index. https://t.co/nKEYPkAs1m BREAKING: MicroStrategy $MSTR is joining the Nasdaq [---] index. https://t.co/nKEYPkAs1m"
X Link 2024-12-14T01:48Z [--] followers, [---] engagements
"#xbi $xbi OTOH this touches the bottom for biotech. Pendulum swing always corrects. #NASDAQ #bullrun #BearBull This probably tops the market. Super bearish. #NASDAQ #bullrun #BearBull This probably tops the market. Super bearish"
X Link 2024-12-14T01:59Z [--] followers, [---] engagements
"$SGMO Market finally believes $PFE is filing BLA when Roche drops HemA. Sandy mentioned cash issue will be solved in this way. They can negotiate Fabry STAC-BBB MINT Tregs Prion new CNS targets.all now in a position of strength. Sit back and enjoy the rocket up"
X Link 2024-12-16T15:36Z [--] followers, [----] engagements
"@RNAiAnalyst $prqr In that case even more so they should diversify away from $LLY. There might be a tussle with other BP on target areas and partnerships. $REGN"
X Link 2024-12-16T16:47Z [--] followers, [----] engagements
"$BIOAB up 32% $1.2b mkt cap. (STO) $SGMO STAC-BBB can surely do better with Genentech and Astellas endorsement. https://www.bioarctic.com/en/bioarctic-announces-global-license-agreement-with-bristol-myers-squibb-for-bioarctics-pyroglutamate-amyloid-beta-antibody-program/ https://www.bioarctic.com/en/bioarctic-announces-global-license-agreement-with-bristol-myers-squibb-for-bioarctics-pyroglutamate-amyloid-beta-antibody-program/"
X Link 2024-12-19T14:35Z [---] followers, [---] engagements
"$NVO $LLY $VKTX Weight loss 22.7% after [--] weeks not way off 25%. Sell on news.as always. $xbi is sick. https://www.statnews.com/2024/12/20/novo-nordisk-cagrisema-obesity-wegovy/ https://www.statnews.com/2024/12/20/novo-nordisk-cagrisema-obesity-wegovy/"
X Link 2024-12-20T12:59Z [--] followers, [---] engagements
"$xbi Reload calls. History will be made today: As the Nasdaq is down over -6% from its high in just [--] days there are a MASSIVE amount of options expiring today. In fact a record $6.6 TRILLION worth of options are expiring based on notional value. What does this mean exactly (a thread) History will be made today: As the Nasdaq is down over -6% from its high in just [--] days there are a MASSIVE amount of options expiring today. In fact a record $6.6 TRILLION worth of options are expiring based on notional value. What does this mean exactly (a thread)"
X Link 2024-12-20T14:44Z [--] followers, [--] engagements
"@auditor112017 @mchilberg $SGMO Astellas probably saw good signals fr Aviado ph1 trial (FTD-GRN) via AVB-101 (AAV9) cohort fully dosed by Oct24. Next logical step is to use STAC-BBB to CNS. 700x"
X Link 2024-12-21T06:13Z [--] followers, [---] engagements
"$ARWR This may be the dark horse in obesity race.and comes with an impressive late stage pipeline. One of [----] top bet. https://arrowheadpharma.com/news-press/arrowhead-pharmaceuticals-initiates-phase-1-2a-study-of-aro-inhbe-for-the-treatment-of-obesity/ https://arrowheadpharma.com/news-press/arrowhead-pharmaceuticals-initiates-phase-1-2a-study-of-aro-inhbe-for-the-treatment-of-obesity/"
X Link 2024-12-23T14:24Z [--] followers, [---] engagements
"#H5N1 #xbi $xbi Next pandemic https://www.statnews.com/2024/12/26/cdc-says-h5n1-bird-flu-sample-shows-mutations-that-may-help-the-virus-bind-to-cells-in-the-upper-airways-of-people/ https://www.statnews.com/2024/12/26/cdc-says-h5n1-bird-flu-sample-shows-mutations-that-may-help-the-virus-bind-to-cells-in-the-upper-airways-of-people/"
X Link 2024-12-27T12:19Z [--] followers, [---] engagements
"$SGMO $PFE Market reaction will be severe investors in for wild ride. Pfizer is well known for dumb decisions. After [--] years and this. STAC-BBB is still in the money Fabry deal is advanced. Focus on the positives for 2025"
X Link 2024-12-31T02:03Z [--] followers, [----] engagements
"@RNAiAnalyst My guess also to protect recurring HEMLIBRA and HYMPAVZI revenues. $sgmo $pfe"
X Link 2024-12-31T08:05Z [--] followers, [---] engagements
"@Franca_ole @JungleJorge2 @sampetherick Was abandoned for dead but revived because of its science. Its new neuro direction is the future. Not HemA. Not pfizer"
X Link 2024-12-31T09:22Z [--] followers, [---] engagements
"$VIR Events to look out for: [--] Jan - T cell engager virtual event [--] Jan - JP Morgan presentation"
X Link 2024-12-31T15:25Z [--] followers, [---] engagements
"#xbi $xbi To be an inter-planetary species we need to be genetically remodelled. [----] bios will shine. Peace. Patience"
X Link 2025-01-01T01:51Z [--] followers, [---] engagements
"@davidycli $xbi #GeneTherapy @elonmusk USA must not lose to China in biotech research and in particular DNA/RNA editing"
X Link 2025-01-02T14:49Z [--] followers, [---] engagements
"$xbi Good start to [----] Xbi 150"
X Link 2025-01-02T16:37Z [--] followers, [--] engagements
"@RNAiAnalyst $VIR #HBV Functional cure readout in Q2. May be sold by then"
X Link 2025-01-08T14:40Z [--] followers, [---] engagements
"$ARWR No JPM presentation despite all the clinical good news and BD. Blackout"
X Link 2025-01-08T14:43Z [--] followers, [---] engagements
"$NTLA $EDIT $CRSP $BEAM GT decimated over past few years cash burn low investor sentiment. What can turn it around https://www.globenewswire.com/news-release/2025/01/09/3007346/0/en/Intellia-Therapeutics-Announces-Anticipated-2025-Milestones-and-Strategic-Reorganization-to-Prioritize-the-Advancement-of-its-Late-Stage-Programs-NTLA-2002-and-Nexiguran-Ziclumeran.html"
X Link 2025-01-10T04:22Z [--] followers, [----] engagements
"$GSK Good omen for the year unicorn deal. https://www.businesswire.com/news/home/20250112698434/en/GSK-Enters-Agreement-to-Acquire-IDRx-Inc https://www.businesswire.com/news/home/20250112698434/en/GSK-Enters-Agreement-to-Acquire-IDRx-Inc"
X Link 2025-01-13T08:30Z [--] followers, [--] engagements
"$MREO Sold significantly before 1st interim readout.key risk was overly high hopes on 1st. https://www.mereobiopharma.com/news-and-events/news/update-on-lead-clinical-programs/ https://www.mereobiopharma.com/news-and-events/news/update-on-lead-clinical-programs/"
X Link 2025-01-13T09:23Z [--] followers, [---] engagements
"$LLY $VKTX $NVO Weight-loss getting slammed. Already warned its too crowded. https://www.bloomberg.com/news/articles/2025-01-14/lilly-2024-sales-miss-estimate-as-weight-loss-drugs-slowsrnd=homepage-asia https://www.bloomberg.com/news/articles/2025-01-14/lilly-2024-sales-miss-estimate-as-weight-loss-drugs-slowsrnd=homepage-asia"
X Link 2025-01-14T14:51Z [--] followers, [---] engagements
"#xbi $xbi The term Colossal failure sounds more familiar. Colossal Biosciences raises $200M at $10.2B valuation to bring back woolly mammoths https://t.co/uonkg29Z7s Colossal Biosciences raises $200M at $10.2B valuation to bring back woolly mammoths https://t.co/uonkg29Z7s"
X Link 2025-01-17T10:44Z [--] followers, [--] engagements
"$ARWR Nice. The FDA provided a Prescription Drug User Fee Act (PDUFA) action date ofNovember [--] [----] https://ir.arrowheadpharma.com/news-releases/news-release-details/arrowhead-pharmaceuticals-announces-acceptance-new-drug https://ir.arrowheadpharma.com/news-releases/news-release-details/arrowhead-pharmaceuticals-announces-acceptance-new-drug"
X Link 2025-01-18T03:49Z [--] followers, [---] engagements
"#xbi $xbi Vibes from new Administration seems very good so far lower interest rates cancer vaccines AI in biotech less regulation gene editing Xbi [---] 🚀"
X Link 2025-01-24T14:38Z [--] followers, [---] engagements
"@mchilberg $sgmo Great observation. Astellas seems to be playing catch up with Roche again $pstx. Maybe this time is different"
X Link 2025-01-25T01:26Z [---] followers, [---] engagements
"$prqr Trading like $wve proof of concept never happened and placement at $3.50 as well. One of my Gems in Bio wasteland. LOL"
X Link 2025-01-30T09:02Z [---] followers, [----] engagements
"$PRQR AAV gene therapy approach to Rett Syndrome $TSHA Estimated 750k sufferers worldwide USA 30k. https://seekingalpha.com/article/4752344-taysha-gene-therapies-is-showing-promise-for-rett-syndrome https://seekingalpha.com/article/4752344-taysha-gene-therapies-is-showing-promise-for-rett-syndrome"
X Link 2025-01-31T02:40Z [---] followers, [---] engagements
"$sgmo $vygr Payload failure not capsid. https://www.globenewswire.com/news-release/2025/02/11/3024034/36461/en/Voyager-Provides-Update-on-SOD1-ALS-Gene-Therapy-Program.html https://www.globenewswire.com/news-release/2025/02/11/3024034/36461/en/Voyager-Provides-Update-on-SOD1-ALS-Gene-Therapy-Program.html"
X Link 2025-02-11T14:19Z [---] followers, [----] engagements
"$xbi #xbi Look past the current figures. Its already falling. *HASSETT: WE WILL FIX INFLATION WITH OR WITHOUT THE FED *HASSETT: WE WILL FIX INFLATION WITH OR WITHOUT THE FED"
X Link 2025-02-12T14:59Z [--] followers, [---] engagements
"$PRQR ADAGE Capital 9.3% stake now. Wow https://www.sec.gov/Archives/edgar/data/1535978/000090266425000880/xslSCHEDULE_13G_X01/primary_doc.xml https://www.sec.gov/Archives/edgar/data/1535978/000090266425000880/xslSCHEDULE_13G_X01/primary_doc.xml"
X Link 2025-02-14T10:48Z [---] followers, [---] engagements
"$SGMO Buyout monday trade again. Nice bounce off lows. This time may be real"
X Link 2025-02-28T15:49Z [---] followers, [----] engagements
"@ZinselmeyerB $SGMO Insiders loaded with options not far from current price. Thats a great signal. This is a GT powerhouse with a great neuro future with Astellas and Genetech. Not SKYPE"
X Link 2025-02-28T16:13Z [---] followers, [---] engagements
"$prqr Wow back to negative EV again. Flush out stop losses again before earnings. Earning release in a week last year [--] March"
X Link 2025-03-06T15:23Z [---] followers, [---] engagements
"$tsvt Next $adap https://www.businesswire.com/news/home/20250310482749/en/2seventy-bio-Enters-into-Definitive-Agreement-to-be-Acquired-by-Bristol-Myers-Squibb https://www.businesswire.com/news/home/20250310482749/en/2seventy-bio-Enters-into-Definitive-Agreement-to-be-Acquired-by-Bristol-Myers-Squibb"
X Link 2025-03-11T02:49Z [---] followers, [---] engagements
"$SGMO Why would they announce a deal here at Barclays Not the right platform and timing. Listen in for nuggets from Sandy"
X Link 2025-03-12T15:42Z [---] followers, [---] engagements
"$mgtx $sgmo Neuro and CNS delivery is confirmed next big area after obesity. $200m upfront here. Roche or Astellas will come for STAC-BBB and the whole suite. https://investors.meiragtx.com/news-releases/news-release-details/meiragtx-enters-strategic-collaboration-hologen-ai-expedite https://investors.meiragtx.com/news-releases/news-release-details/meiragtx-enters-strategic-collaboration-hologen-ai-expedite"
X Link 2025-03-13T12:13Z [---] followers, [---] engagements
"$prqr 1/2 Mcap $184m mid [----]. -EV [--] key items [----] AX-0810 CTA mid-yr readout year-end AX-1412 mid-yr optimization for GalNAc delivery https://www.proqr.com/press-releases/proqr-announces-year-end-2024-operating-and-financial-results https://www.proqr.com/press-releases/proqr-announces-year-end-2024-operating-and-financial-results"
X Link 2025-03-14T03:27Z [---] followers, [---] engagements
"$sgmo Having a Monday earnings release means they are putting final ink to a deal and wants to seal it. If terms dont work then prob a $20m to $30m financing to tide over till the big deals $200m land. Similar to a year ago. Take advantage of it"
X Link 2025-03-17T02:45Z [---] followers, [----] engagements
"$sgmo In this game risk management is paramount. I can afford to lose 1x of my bet on Sangamo but cannot afford to miss 10x the gains when it becomes a neuro-powerhouse. $sgmo Having a Monday earnings release means they are putting final ink to a deal and wants to seal it. If terms dont work then prob a $20m to $30m financing to tide over till the big deals $200m land. Similar to a year ago. Take advantage of it. $sgmo Having a Monday earnings release means they are putting final ink to a deal and wants to seal it. If terms dont work then prob a $20m to $30m financing to tide over till the"
X Link 2025-03-18T13:52Z [---] followers, [---] engagements
"$prqr $lly About time to unveil. https://www.sitryx.com/news/sitryx-announces-partner-lilly-exercises-option-to-sit-011-for-chronic-autoimmune-and-inflammatory-diseases https://www.sitryx.com/news/sitryx-announces-partner-lilly-exercises-option-to-sit-011-for-chronic-autoimmune-and-inflammatory-diseases"
X Link 2025-03-21T07:23Z [---] followers, [---] engagements
"$xbi $ntla $edit $beam $crsp $verv $sln $arwr $wve $krro $prqr $sgmo $mgx $qure #xbi So GT stocks plunge due to RK FDA future. The science continues. The diseases are still there. Follow the smart money. Be contrarian"
X Link 2025-04-01T01:39Z [---] followers, [----] engagements
"$sgmo $lly Its now a [--] way race to Sangamo prized assets eventually - Genentech Astellas and now Lily. The delay could be due to buyout negotiations. Perfect fit for Prevail which is a Lily sub. $sgmo Enough bridge to a Fabry deal. Excellent Sandy delivered. https://t.co/PMuajmsI6W $sgmo Enough bridge to a Fabry deal. Excellent Sandy delivered. https://t.co/PMuajmsI6W"
X Link 2025-04-04T01:54Z [---] followers, [---] engagements
"$VIR Cash $1.1b 2Q catalyst - HBV [--] weeks off treatment data soon. HDV is a home run but only 10% of HBV market. Perhaps $1-2b"
X Link 2025-04-09T16:17Z [---] followers, [---] engagements
"$pfe $sgmo They do bad science and abandon good science. Worst company. Stock shows beyond covid lows to GFC lows. https://www.statnews.com/2025/04/14/pfizer-discontinue-danuglipron-glp-1-obesity-liver-toxicity/ https://www.statnews.com/2025/04/14/pfizer-discontinue-danuglipron-glp-1-obesity-liver-toxicity/"
X Link 2025-04-14T12:09Z [---] followers, [---] engagements
"@BiotechAnalysst $pfe Buying another obese company will seal its FATe. LOL"
X Link 2025-04-15T00:11Z [---] followers, [--] engagements
"$VIR Upcoming data EASL [----] from [--] to [--] May. Above 30% would be great"
X Link 2025-04-21T14:52Z [---] followers, [---] engagements
"$SLN Cash to [----]. $147m. Mkt cap $50m. Can zerlasiran find a suitor Its a big market for all but this is sold down so much. https://www.fiercebiotech.com/biotech/lilly-links-lepodisiran-durably-lower-lipoprotein-phase-2-providing-edge-over-amgen-and https://www.fiercebiotech.com/biotech/lilly-links-lepodisiran-durably-lower-lipoprotein-phase-2-providing-edge-over-amgen-and"
X Link 2025-04-23T14:13Z [---] followers, [---] engagements
"$SGMO Good volume and price today. Smelling a whiff of a deal next Monday"
X Link 2025-04-24T14:04Z [---] followers, [---] engagements
"$swtx #xbi $xbi This will unlock more flow in deals. Good sign. https://www.businesswire.com/news/home/20250427077657/en/Merck-KGaA-Darmstadt-Germany-to-Acquire-US-Biopharma-Company-SpringWorks-Therapeutics-to-Accelerate-Sustainable-Growth-of-Healthcare-Business https://www.businesswire.com/news/home/20250427077657/en/Merck-KGaA-Darmstadt-Germany-to-Acquire-US-Biopharma-Company-SpringWorks-Therapeutics-to-Accelerate-Sustainable-Growth-of-Healthcare-Business"
X Link 2025-04-28T11:48Z [---] followers, [---] engagements
"$prqr On track. "During the first quarter of [----] the Company achieved a milestone in the collaboration agreement with Eli Lilly earning $1.0 million." https://www.proqr.com/press-releases/proqr-announces-first-quarter-2025-operating-and-financial-resultsutm_source=Newsletter&utm_medium=email&utm_campaign=PR_emailalerts https://www.proqr.com/press-releases/proqr-announces-first-quarter-2025-operating-and-financial-resultsutm_source=Newsletter&utm_medium=email&utm_campaign=PR_emailalerts"
X Link 2025-05-08T13:49Z [---] followers, [---] engagements
"$sgmo Earnings call after market close today. Major US-China trade descalation. Coincidence Always watch mondays for a deal but this is special"
X Link 2025-05-12T07:51Z [---] followers, [---] engagements
"$arwr Solid quarter. Continues to deliver in clinic and BD. https://ir.arrowheadpharma.com/news-releases/news-release-details/arrowhead-pharmaceuticals-reports-fiscal-2025-second-quarter https://ir.arrowheadpharma.com/news-releases/news-release-details/arrowhead-pharmaceuticals-reports-fiscal-2025-second-quarter"
X Link 2025-05-12T23:32Z [---] followers, [---] engagements
"$SGMO Live another quarter to tell another story. Warrant price 75cts offering combined 50cts. Not Fabry deal yet as many expected but as always risk management is key in biotech. https://investor.sangamo.com/news-releases/news-release-details/sangamo-therapeutics-announces-pricing-230-million-underwritten https://investor.sangamo.com/news-releases/news-release-details/sangamo-therapeutics-announces-pricing-230-million-underwritten"
X Link 2025-05-12T23:45Z [---] followers, [---] engagements
"$ARWR Cheapest siRNA yet with multiple late stage p3 this year. If cards fall in place next $ALNY potential. https://news.abbvie.com/2025-05-14-AbbVie-and-ADARx-Pharmaceuticals-Announce-Collaboration-and-License-Option-Agreement-to-Develop-Next-Generation-siRNA-Therapies-Across-Multiple-Therapeutic-Areas https://news.abbvie.com/2025-05-14-AbbVie-and-ADARx-Pharmaceuticals-Announce-Collaboration-and-License-Option-Agreement-to-Develop-Next-Generation-siRNA-Therapies-Across-Multiple-Therapeutic-Areas"
X Link 2025-05-15T11:23Z [---] followers, [----] engagements
"$ntla $prme $edit $crsp $prqr $wve $krro $verve $beam #dna #rna $xbi #xbi Get ready for short squeezes. Hot Monday. Intellia announces positive two-year follow-up data from its ongoing Phase [--] study in #ATTR with polyneuropathy at the [----] @PNSociety1 Annual Meeting in Edinburgh (https://t.co/uHhguJ9OI2). HCPs: be sure to catch our oral and poster presentation and stop by our booth to meet our https://t.co/JDzKAsNzCf Intellia announces positive two-year follow-up data from its ongoing Phase [--] study in #ATTR with polyneuropathy at the [----] @PNSociety1 Annual Meeting in Edinburgh"
X Link 2025-05-19T05:31Z [---] followers, [----] engagements
"$SLN mRNAi Gold platform owns all IP of siRNA modification delivery construct etc. [--] patents. Phase [--] ready for CVD. Cash to [----]. Attractive target. Regulus and ADARx. $SLN Cash to [----]. $147m. Mkt cap $50m. Can zerlasiran find a suitor Its a big market for all but this is sold down so much. https://t.co/qDYXZV7rU9 $SLN Cash to [----]. $147m. Mkt cap $50m. Can zerlasiran find a suitor Its a big market for all but this is sold down so much. https://t.co/qDYXZV7rU9"
X Link 2025-05-19T15:00Z [---] followers, [---] engagements
"$CRSP $SLN Interesting. DNA editing to RNAi. Another siRNA deal. Matter of time. https://ir.crisprtx.com/news-releases/news-release-details/crispr-therapeutics-and-sirius-therapeutics-announce-multi https://ir.crisprtx.com/news-releases/news-release-details/crispr-therapeutics-and-sirius-therapeutics-announce-multi"
X Link 2025-05-20T11:38Z [---] followers, [---] engagements
"$SLN $ARWR Cannot contain my excitement. Another RNAi gets scooped up. https://www.globenewswire.com/news-release/2025/05/27/3088497/0/en/Biogen-and-City-Therapeutics-Announce-Strategic-Research-Collaboration-to-Develop-Select-Novel-RNAi-based-Therapies.html https://www.globenewswire.com/news-release/2025/05/27/3088497/0/en/Biogen-and-City-Therapeutics-Announce-Strategic-Research-Collaboration-to-Develop-Select-Novel-RNAi-based-Therapies.html"
X Link 2025-05-30T03:31Z [---] followers, [---] engagements
"#xbi $xbi Seems like deals are coming fast anf furious. https://www.globenewswire.com/news-release/2025/06/02/3091541/0/en/Press-Release-Sanofi-to-acquire-Blueprint-Medicines-expanding-portfolio-in-rare-immunological-disease-and-adding-early-stage-pipeline-in-immunology.html https://www.globenewswire.com/news-release/2025/06/02/3091541/0/en/Press-Release-Sanofi-to-acquire-Blueprint-Medicines-expanding-portfolio-in-rare-immunological-disease-and-adding-early-stage-pipeline-in-immunology.html"
X Link 2025-06-02T05:29Z [---] followers, [---] engagements
"@US_FDA @SecKennedy @DrMakaryFDA @DrOz @NIHDirector_Jay $SGMO Start with Hemophilia A and Fabry disease 👍. Sangamo is right at the doorstep with cures for both and is almost running out of money doing the right science. Give them a lifeline and tens of thousands will be cured. After this weeks cell and gene therapy roundtable at @US_FDA @SecKennedy joined @DrOzCMS @DrMakaryFDA and @NIHDirector_Jay to deliver a message directly to the American people about investing in cutting-edge cures. Cell and gene therapy holds promisebut it also demands https://t.co/sEC3tYZTxp After this weeks cell and"
X Link 2025-06-08T08:46Z [---] followers, [----] engagements
"@HHSGov @SecKennedy @US_FDA @DrOzCMS @DrMakaryFDA @NIHDirector_Jay Start with Hemophilia A and Fabry disease 👍. Sangamo $sgmo is right at the doorstep with cures for both and is almost running out of money doing the right science. Give them a lifeline and tens of thousands will be cured"
X Link 2025-06-08T08:55Z [---] followers, [---] engagements
"$verv Spending $1b is chum change for Lily. Too cheap. https://www.ft.com/content/53d021c9-d15f-4471-86ef-e9abfc3ae7db https://www.ft.com/content/53d021c9-d15f-4471-86ef-e9abfc3ae7db"
X Link 2025-06-17T03:40Z [---] followers, [---] engagements
"@pawcio2009 Morgan Stanley expects [--] rate cuts in [----]. Whole lot of us going bio heaven next year. LOL"
X Link 2025-06-26T08:09Z [---] followers, [--] engagements
"$xbi #xbi Morgan Stanley expects [--] rate cuts in [----]. And perhaps [--] this year. Nice setup to xbi 120"
X Link 2025-07-02T15:05Z [---] followers, [---] engagements
"$prme $ntla $beam $editas $crsp $mgx $sgmo $prqr $wve $krro With bio sentiment recovering and long weekend plus rate cuts bet on a DNA/RNA editing name being acquired next few weeks"
X Link 2025-07-03T03:10Z [---] followers, [---] engagements
"#xbi $xbi Don't sell your winners now that we are on the verge of a new bull in biotech. Many names will 10x some even 100x. SoftBank was the largest shareholder of Nvidia. but they sold their entire 4.9% stake in Nvidia in [----] for $3.6B. It's worth $200B today. Jensen Huang made fun of Masa in front of him is so funny lmao https://t.co/a6qeNbhDtR SoftBank was the largest shareholder of Nvidia. but they sold their entire 4.9% stake in Nvidia in [----] for $3.6B. It's worth $200B today. Jensen Huang made fun of Masa in front of him is so funny lmao https://t.co/a6qeNbhDtR"
X Link 2025-07-14T14:49Z [---] followers, [---] engagements
"$vtyx Very decent upside as it is below cash Mkt cap only $210m and compared to $VKTX $3.2b. Seriously should reject any Sanofi offer below $1b. $vtyx Market cap $180m below cash and with two large indications of Parkinsons and Obesity. Nice rebound off lows. Impt readout end of Q3. $vtyx Market cap $180m below cash and with two large indications of Parkinsons and Obesity. Nice rebound off lows. Impt readout end of Q3"
X Link 2025-07-15T16:58Z [---] followers, [---] engagements
"$vtyx Both Ventyx and Nodthera preclinical results show enhanced weight loss and other parameters with semaglutide. This represents a new approach to obesity treatment using NRLP3 inflammasome inhibitor. See if there is any pullback to add. $vktx mc is $3.6b here only $230m"
X Link 2025-07-18T06:44Z [---] followers, [---] engagements
"$mgx Market cap of only $80m with cash of over $200m. Platform looks really good. Pipeline just a tad earlier than $prme"
X Link 2025-07-23T14:36Z [---] followers, [---] engagements
"$mgx 1/5 the market cap of $prme but twice the cash. Hope they throw off Hem A and go big on cardio"
X Link 2025-07-28T14:37Z [---] followers, [---] engagements
"$prqr Also one month out to CTA submission for AX-0810 on [--] June. Expect approval soon"
X Link 2025-07-28T15:03Z [---] followers, [---] engagements
"$prme Better late than never responsible raise with some dilution. https://www.globenewswire.com/news-release/2025/07/31/3124616/0/en/Prime-Medicine-Announces-Pricing-of-Public-Offering.html https://www.globenewswire.com/news-release/2025/07/31/3124616/0/en/Prime-Medicine-Announces-Pricing-of-Public-Offering.html"
X Link 2025-07-31T13:22Z [---] followers, [---] engagements
"$arwr Becoming late stage commercial soon once approved.re-rating due. Today we announced the signing of an asset purchase agreement between Sanofi and Visirna a subsidiary of Arrowhead to develop and commercialize investigational plozasiran in Greater China Learn more in our press release here: https://t.co/oOwVDRKfG3 https://t.co/uAdfcq17Kw Today we announced the signing of an asset purchase agreement between Sanofi and Visirna a subsidiary of Arrowhead to develop and commercialize investigational plozasiran in Greater China Learn more in our press release here: https://t.co/oOwVDRKfG3"
X Link 2025-08-01T11:08Z [---] followers, [---] engagements
"$prqr "Hosting fall Analyst and Investor Event (virtual) featuring detailed AX-0810 Phase [--] trial design and [----] data expectations plus updates across differentiated liver and CNS pipeline" https://www.proqr.com/press-releases/proqr-announces-second-quarter-2025-operating-and-financial-results https://www.proqr.com/press-releases/proqr-announces-second-quarter-2025-operating-and-financial-results"
X Link 2025-08-07T12:37Z [---] followers, [----] engagements
"$prqr Finally some data for [----] and CTA approval coming"
X Link 2025-08-07T12:39Z [---] followers, [---] engagements
"#xbi $xbi "President Trump has explicitly stated that his new Fed Chair pick must cut rates." Party time. Fed Chair Powell has caved: In [--] month the Fed will CUT rates and blame a "weaker labor market." Meanwhile we now have PPI inflation growth at a 3-year high and CPI inflation above 2% for 53-STRAIGHT months. Don't own assets You will be left behind. Here's why. (a thread) https://t.co/E1pFkDJbIQ Fed Chair Powell has caved: In [--] month the Fed will CUT rates and blame a "weaker labor market." Meanwhile we now have PPI inflation growth at a 3-year high and CPI inflation above 2% for"
X Link 2025-08-24T09:40Z [---] followers, [---] engagements
"$SRPT [--] Aug should be 5th trading day of convertible note pricing issuance close [--] Aug. Debt pushed back to [----] with some dilution. Still a good situation especially if non-ambulatory resumes. Been more than [--] months since suspension on [--] June"
X Link 2025-08-26T23:56Z [---] followers, [---] engagements
"$arwr $200m upfront for a preclinical. Market is not paying enough attention yet. https://ir.arrowheadpharma.com/news-releases/news-release-details/arrowhead-pharmaceuticals-and-novartis-enter-global-license-and https://ir.arrowheadpharma.com/news-releases/news-release-details/arrowhead-pharmaceuticals-and-novartis-enter-global-license-and"
X Link 2025-09-02T13:42Z [---] followers, [---] engagements
"@BiomedicalRX $arwr More than 10x difference in market cap $alny and 2.5x with $IONS. Surely potential for further upside early innings here. Adding"
X Link 2025-09-03T10:49Z [---] followers, [---] engagements
"$QURE "AMT-191 showed a manageable safety profile." Two SAEs out of [--] patients at higher dose. Second cohort with 1/3 dose seems much better. Still much farther behind than $sgmo with excellent safety and BLA early 2026"
X Link 2025-09-05T13:44Z [---] followers, [---] engagements
"$arwr Why are we are not at $5b already with such an excellent pipeline. https://ir.arrowheadpharma.com/news-releases/news-release-details/arrowhead-pharmaceuticals-requests-regulatory-clearance-0 https://ir.arrowheadpharma.com/news-releases/news-release-details/arrowhead-pharmaceuticals-requests-regulatory-clearance-0"
X Link 2025-09-10T14:03Z [---] followers, [---] engagements
"$sgmo $arvn $pfe At least Sangamo owns the whole HemA drug. This is like a jilted lover refusing to leave. Another dump by Pfizer. https://ir.arvinas.com/news-releases/news-release-details/arvinas-provides-update-collaboration-pfizer-and-announces/ https://ir.arvinas.com/news-releases/news-release-details/arvinas-provides-update-collaboration-pfizer-and-announces/"
X Link 2025-09-18T09:12Z [---] followers, [---] engagements
"$arvn $pfe $sgmo Called it. Pfizer is the worst partner. They dump both good and bad drugs. $arvn $pfe $sgmo Looks like Pfizer may jilt this one too https://t.co/9SkPTrC9ns $arvn $pfe $sgmo Looks like Pfizer may jilt this one too https://t.co/9SkPTrC9ns"
X Link 2025-09-18T10:35Z [---] followers, [---] engagements
"@commonsenseplay $srpt The pressure to release the hold in non-ambulatory builds"
X Link 2025-09-19T01:14Z [---] followers, [---] engagements
"$pfe $vktx Pfizer famously overpaid for Seagen. About to repeat the same mistake paying almost 3x mkt cap of Viking.only time will tell. https://finance.yahoo.com/news/pfizer-closes-7-3-billion-040417337.html https://finance.yahoo.com/news/pfizer-closes-7-3-billion-040417337.html"
X Link 2025-09-22T10:51Z [---] followers, [---] engagements
"$mgx $prme Similar cash levels around $200m one is a unicorn soon and the other languishing at 10% market cap only. Star scientist pull is really strong but I like the setup here"
X Link 2025-09-24T14:27Z [---] followers, [---] engagements
"$vtyx 1/3 Nice close above $3 to begin Q4. Ventyx should be the furthest in the field of NRLP3 human trials imminent data early Oct"
X Link 2025-09-30T01:03Z [---] followers, [---] engagements
"2/3 NLRP3 contains a PRYIN domain (PYD) a nucleotide binding and oligomerization domain (NACHT) an N-terminal caspase activation and recruitment domain (CARD) and a C-terminal leucine-rich repeats (LRRs)"
X Link 2025-09-30T01:10Z [---] followers, [---] engagements
"$xbi #xbi Xbi should gain strength towards end of the year. Interest rates got to go way down. It is a tailwind. ADP REPORT: NUMBER OF JOBS CREATED IN AUGUST WAS REVISED TO [-----] FROM [-----] ADP REPORT: NUMBER OF JOBS CREATED IN AUGUST WAS REVISED TO [-----] FROM 54000"
X Link 2025-10-01T13:02Z [---] followers, [---] engagements
"$pali 70cts Not even giving a decent premium for price discovery. Stockholders massive dilution. https://www.globenewswire.com/news-release/2025/10/02/3160698/0/en/Palisade-Bio-Announces-Closing-of-Upsized-138-Million-Public-Offering-of-Common-Stock-and-Including-Full-Exercise-of-Over-Allotment-Option.html https://www.globenewswire.com/news-release/2025/10/02/3160698/0/en/Palisade-Bio-Announces-Closing-of-Upsized-138-Million-Public-Offering-of-Common-Stock-and-Including-Full-Exercise-of-Over-Allotment-Option.html"
X Link 2025-10-03T08:49Z [---] followers, [---] engagements
"@RNAiAnalyst $mgx Just need a spark to ignite FOMO here"
X Link 2025-10-07T02:24Z [---] followers, [---] engagements
"$srpt Seems the younger they are the better chances of reversing this deadly disease. $SRPT WMS [----] a) no Treatment related SAEs in 3-4 years old (ambulatory).no new safety signals b) micro-dystrophin expression is higher in 3-4 years old compare to =5 years of age https://t.co/bninAqJW6S $SRPT WMS [----] a) no Treatment related SAEs in 3-4 years old (ambulatory).no new safety signals b) micro-dystrophin expression is higher in 3-4 years old compare to =5 years of age https://t.co/bninAqJW6S"
X Link 2025-10-08T05:07Z [---] followers, [----] engagements
"$vtyx Reminder Sanofi acquired Vigil for $470m + $100m CVR single Alzheimer's. Parkinson's Cardiometabolic and Recurrent Pericarditis should go for no less than $1b. A great quarter to drop good data"
X Link 2025-10-08T06:51Z [---] followers, [---] engagements
"$xbi #xbi The deals keep coming every week.healthy sign of more to come https://www.wsj.com/health/pharma/johnson-johnson-in-talks-to-buy-protagonist-therapeutics-38e0b69d https://www.wsj.com/health/pharma/johnson-johnson-in-talks-to-buy-protagonist-therapeutics-38e0b69d"
X Link 2025-10-11T07:01Z [---] followers, [--] engagements
"@Soeren_Berlin @ZinselmeyerB $sgmo Mostly milestone money. The real moolah is not spent yet"
X Link 2025-10-15T01:11Z [---] followers, [---] engagements
"$xbi #xbi $omer And yet another rare disease. https://www.globenewswire.com/news-release/2025/10/15/3167091/0/en/Novo-Nordisk-and-Omeros-announce-asset-purchase-and-license-agreement-for-Omeros-clinical-stage-MASP-3-inhibitor-zaltenibart-OMS906.html https://www.globenewswire.com/news-release/2025/10/15/3167091/0/en/Novo-Nordisk-and-Omeros-announce-asset-purchase-and-license-agreement-for-Omeros-clinical-stage-MASP-3-inhibitor-zaltenibart-OMS906.html"
X Link 2025-10-15T13:32Z [---] followers, [---] engagements
"@yaireinhorn @igisci @RNAiAnalyst $MGX Metagenomi should reverse course and cut HemA trial. Tackle the bigger indications like Alzheimers'. Jill Banfield was co-founder of Metagenomi. Now Brian the other founder is out and it is LOST"
X Link 2025-11-21T07:45Z [---] followers, [---] engagements
"$kron Calling Tang and others attractive dismantle works here. Cash $160m est"
X Link 2024-03-02T02:21Z [---] followers, [---] engagements
"$KRON Extend cash to 2H [----] lots data coming add on dips here"
X Link 2024-03-08T14:13Z [---] followers, [---] engagements
"$SGMO 2/2 If there is no deal why did the Board not undertake strategic review and 50% or 75% layoffs in Q1 like what $GLTO $AVRO and many others have done. Lean down and solicit asset/IP sales. Patience but risk adjust please. Only invest what you can lose completely. $SGMO 1/2 It takes time to conclude deals.at least [--] months to as long as a year or more. Likely shorts will pull this down below 50s again.patience is the most difficult thing. $SGMO 1/2 It takes time to conclude deals.at least [--] months to as long as a year or more. Likely shorts will pull this down below 50s again.patience is"
X Link 2024-06-15T05:05Z [---] followers, [----] engagements
"$ACHL $95m cash last mkt cap $29m. Finally. https://ir.achillestx.com/news-releases/news-release-details/achilles-therapeutics-announces-strategic-update https://ir.achillestx.com/news-releases/news-release-details/achilles-therapeutics-announces-strategic-update"
X Link 2024-09-19T12:31Z [---] followers, [--] engagements
"$wve $prqr $krro Fantastic news https://ir.wavelifesciences.com/news-releases/news-release-details/wave-life-sciences-announces-first-ever-therapeutic-rna-editing https://ir.wavelifesciences.com/news-releases/news-release-details/wave-life-sciences-announces-first-ever-therapeutic-rna-editing"
X Link 2024-10-16T13:36Z [---] followers, [---] engagements
"$cdmo $xbi The M&A spigot is on. https://ir.avidbio.com/news-releases/news-release-details/avid-bioservices-be-acquired-gho-capital-partners-and-ampersand https://ir.avidbio.com/news-releases/news-release-details/avid-bioservices-be-acquired-gho-capital-partners-and-ampersand"
X Link 2024-11-07T05:20Z [---] followers, [----] engagements
"$arwr Unbelievable this is still stuck at $22 after the BD with $SRPT clinical updates and all. What can save this sector Just buyout. Only farts and shitcoins matter"
X Link 2024-12-13T15:13Z [---] followers, [---] engagements
"@ZinselmeyerB @Gr8unionsJohn @adamfeuerstein @SangamoTx $SGMO HCW - short term financing is always an option. Believe Fabry deal is close past [--] months now. $ADVM the other presentee juiced up $127.5m 20% premium [--] year ago. https://investors.adverum.com/press_releases/news-details/2024/Adverum-Biotechnologies-Announces-127.5-Million-Private-Placement-Financing/default.aspx https://investors.adverum.com/press_releases/news-details/2024/Adverum-Biotechnologies-Announces-127.5-Million-Private-Placement-Financing/default.aspx"
X Link 2025-01-14T01:59Z [---] followers, [----] engagements
"$TECX $AVRO Previously Avrobio. Thats why reverse mergers are sometimes great https://investors.tectonictx.com/news-releases/news-release-details/tectonic-therapeutic-announces-positive-interim-data-phase-1b https://investors.tectonictx.com/news-releases/news-release-details/tectonic-therapeutic-announces-positive-interim-data-phase-1b"
X Link 2025-01-31T02:45Z [---] followers, [---] engagements
"@BiotechAnalysst @mchilberg Astellas zeroing fast on $sgmo who would'nt Two BLA ready drugs this year STAC-BBB MINT is the future. Its maybe a bidding war with Roche. Poseida redux"
X Link 2025-02-13T16:08Z [--] followers, [---] engagements
"$VTYX Forget Crohn main event is Parkinsons in H1 [----] and NLRP3 for obesity in H2 [----]. Market cap $117m cash $253m. https://ir.ventyxbio.com/news-releases/news-release-details/ventyx-biosciences-highlights-2025-pipeline-strategy-and https://ir.ventyxbio.com/news-releases/news-release-details/ventyx-biosciences-highlights-2025-pipeline-strategy-and"
X Link 2025-02-19T15:16Z [--] followers, [---] engagements
Limited data mode. Full metrics available with subscription: lunarcrush.com/pricing